###begin article-title 0
Apolipoprotein E gene is related to mortality only in normal weight individuals: The Rotterdam study
###end article-title 0
###begin p 1
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Objective</italic>
###xml 72 76 72 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 161 180 161 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Methods and Results</italic>
###xml 336 340 336 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 516 517 516 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 547 548 547 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 568 573 568 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 689 694 689 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 776 781 776 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 889 894 889 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 1007 1017 1007 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Conclusion</italic>
###xml 1022 1027 1022 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 718 725 <span type="species:ncbi:9606">persons</span>
###xml 866 873 <span type="species:ncbi:9606">persons</span>
Objective To investigate the relationship between the apolipoprotein E (APOE) gene and the risk of mortality in normal weight, overweight and obese individuals. Methods and Results In a population-based study of 7,983 individuals aged 55 years and older, we compared the risks of all-cause and coronary heart disease (CHD) mortality by APOE genotype, both overall and in subgroups defined by body mass index (BMI). We found significant evidence for interaction between APOE and BMI in relation to total cholesterol (p = 0.04) and HDL cholesterol (p < 0.001). Overall, APOE*2 carriers showed a decreased risk of all-cause mortality. Analyses within BMI strata showed a beneficial effect of APOE*2 only in normal weight persons (adjusted hazard ratio (HR) 0.7[95% CI 0.5-0.9]). APOE*2 was not associated with a lower risk of all-cause mortality in overweight or obese persons. The effect of APOE*2 in normal weight individuals tended to be due to the risk of CHD mortality (adjusted HR 0.5 [95% CI 0.2-1.2]). Conclusion The APOE*2 allele confers a lower risk of all-cause mortality only to normal weight individuals.
###end p 1
###begin title 2
Keywords
###end title 2
###begin p 3
###xml 205 210 187 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 213 217 195 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 224 229 206 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 351 352 333 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 414 418 396 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 435 440 417 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 499 504 481 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 541 546 523 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 561 562 543 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 563 564 545 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
Apolipoprotein E is a plasma protein involved in the metabolism of cholesterol. The apolipoprotein E isoforms epsilon2, epsilon3 and epsilon4, determined by the three alleles of the apolipoprotein E gene (APOE*2, APOE*3 and APOE*4), differ in their binding affinity to serum cholesterol and hence in their ability to clear dietary fat from the blood [1]. Accordingly, total serum cholesterol levels differ between APOE genotypes, with APOE*2 carriers having lower total serum cholesterol levels and APOE*4 carriers having higher levels than APOE*3 homozygotes [1-4].
###end p 3
###begin p 4
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 126 131 126 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 205 210 205 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 331 336 331 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 435 440 435 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 443 444 443 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 447 452 447 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 506 507 506 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 513 518 513 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 540 541 540 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 542 544 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 602 604 602 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 605 607 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
In line with the clear differences in total serum cholesterol levels associated with the APOE genotype, one would expect that APOE*2 carriers have lower risks of cardiovascular morbidity and mortality and APOE*4 carriers have higher risks. Yet, the evidence for this association is inconsistent. A recent meta-analysis showed that APOE*4 was associated with a higher risk of coronary heart disease (CHD), but found no association with APOE*2 [5]. APOE*2 has been associated with a lower risk of mortality [6] and APOE*4 with a higher risk [7-11], but also these relationships were not found by others [12-19].
###end p 4
###begin p 5
###xml 158 162 158 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 328 333 328 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 360 365 360 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 456 461 456 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 473 475 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
###xml 488 493 488 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 640 645 640 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 663 668 663 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 680 682 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 791 795 791 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 836 840 836 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
A possible explanation for these inconsistencies may be found in the role of body weight. Several studies have demonstrated that the relationship between the APOE gene and lipids differs between normal weight, overweight and obese individuals [20-22]. Total serum cholesterol levels were higher among obese than among non-obese APOE*4 carriers [20], and obese APOE*2 carriers had higher serum triglycerides and higher LDL-cholesterol levels than non-obese APOE*2 carriers [20, 21]. While APOE*2 carriers generally have the lowest cholesterol levels, those with high BMI were found to have similar total serum cholesterol levels compared to APOE*3 homozygotes and APOE*4 carriers [20]. These findings suggest that the adverse effects of high body weight may outweigh the beneficial effect of APOE*2 status. If so, a protective effect of APOE*2 on mortality may be largest among normal weight individuals.
###end p 5
###begin p 6
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 215 219 215 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 345 349 345 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
Despite this evidence for a moderating effect of body weight on the relation between the APOE gene and total serum cholesterol, no studies so far have performed a stratified analysis on the relationship between the APOE gene and the risk of mortality. The aim of the present study was to investigate the extent to which the relationship between APOE genotypes and the risk of mortality differs between normal weight, overweight and obese individuals. We examined this relationship for both all-cause and CHD mortality.
###end p 6
###begin title 7
Methods
###end title 7
###begin title 8
Study population and procedures
###end title 8
###begin p 9
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 146 153 <span type="species:ncbi:9606">persons</span>
###xml 427 439 <span type="species:ncbi:9606">participants</span>
###xml 624 636 <span type="species:ncbi:9606">participants</span>
The present analyses were performed in the Rotterdam Study, an ongoing population-based study on the determinants of disease and disability among persons 55 years and older. Details of this study have been described elsewhere [23]. Baseline data were collected between 1990 and 1993. During home visits, a trained investigator obtained information on health status, medical history, medication use and lifestyle. Subsequently, participants were invited to the study center where they underwent an extensive clinical examination. The Medical Ethics Committee of the Erasmus Medical Center approved the study protocol and all participants provided written informed consent. From 10,275 eligible subjects, 7,983 (78%) individuals agreed to participate in the study and were examined at baseline.
###end p 9
###begin title 10
Data collection
###end title 10
###begin title 11
Clinical and laboratory assessments
###end title 11
###begin p 12
###xml 243 244 243 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 307 308 307 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 335 336 335 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 354 355 352 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 377 378 375 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 396 397 392 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 424 425 418 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 428 430 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">24</xref>
###xml 996 998 990 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">25</xref>
###xml 1137 1139 1131 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
###xml 1240 1242 1234 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">27</xref>
###xml 1331 1333 1325 1327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">28</xref>
###xml 1340 1344 1334 1338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 1486 1488 1480 1482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">29</xref>
###xml 1510 1514 1504 1508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 1530 1534 1524 1528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 1545 1549 1539 1543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 1561 1565 1555 1559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 1576 1580 1570 1574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 1592 1596 1586 1590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 1611 1615 1605 1609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 1649 1653 1643 1647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 1712 1713 1706 1707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 247 259 <span type="species:ncbi:9606">Participants</span>
The clinical examination included weight, height, systolic and diastolic blood pressure, serum glucose, total serum cholesterol and high-density lipoprotein (HDL) cholesterol levels. BMI was computed as weight (kg) divided by height squared (m2). Participants were classified as underweight (BMI < 18.5 kg/m2), normal weight (18.5 kg/m2 </= BMI < 25 kg/m2), overweight (25 kg/m2 </= BMI < 30 kg/m2) or obese (BMI >/= 30 kg/m2) [24]. The waist and hip circumferences were measured, and the waist-hip-ratio (WHR) was calculated as indirect assessment of abdominal fat. Systolic and diastolic blood pressures were measured twice in a sitting position after 5 min rest using a random-zero sphygmomanometer. The mean of the two measurements was used for the analyses. Hypertension was defined as systolic blood pressure higher than 160 mmHg, diastolic blood pressure higher than 100 mmHg, or the use of antihypertensive medication indicated to treat high blood pressure (hypertension grades 2 and 3) [25]. Diabetes was diagnosed based on a random or post-load glucose level higher than 11.0 mmol/l and/or the use of anti-diabetic medication [26]. Total serum cholesterol and HDL-cholesterol were measured using an automated enzymatic procedure [27]. Hypercholesterolemia was defined as a total serum cholesterol level above 6.2 mmol/l [28]. The APOE genotype was determined on DNA samples using a polymerase chain reaction followed by enzymatic digestion using methods previously described [29]. The frequencies of APOE genotypes were APOE 2/2 0.8%, APOE 2/3 12.8%, APOE 2/4 2.7%, APOE 3/3 58.4%, APOE 3/4 22.9% and APOE 4/4 2.4%. The proportions of the APOE alleles and genotypes were in Hardy-Weinberg equilibrium (p = 0.71).
###end p 12
###begin title 13
Mortality data
###end title 13
###begin p 14
###xml 459 461 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">30</xref>
###xml 39 51 <span type="species:ncbi:9606">participants</span>
Information on the vital status of the participants was obtained at regular intervals from the municipal population registry. Causes of death were obtained from the general practitioners by means of a standardized questionnaire relating to the circumstances of death, most likely cause of death and time and place of death. Two independent research physicians coded all events according to the International Classification of Diseases, 10th edition (ICD-10) [30]. CHD mortality was defined as death from diseases coded I20-I25, I46, I50 or R96. Mortality data were available up to December 2003.
###end p 14
###begin title 15
Statistical analyses
###end title 15
###begin p 16
###xml 71 75 71 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 302 303 302 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 305 306 305 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 352 356 352 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 406 407 406 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 448 452 448 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 172 179 <span type="species:ncbi:9606">persons</span>
###xml 499 511 <span type="species:ncbi:9606">participants</span>
Of the 7,983 individuals who participated at baseline, 5,817 (73%) had APOE genotyped successfully and had complete information on BMI, WHR and cholesterol levels. Because persons with an extremely low BMI may suffer from life-threatening diseases such as cancer, individuals with a BMI below 18.5 kg/m2 (n = 51) were excluded from the analyses. Also, APOE 2/4 individuals were excluded from the analyses (n = 158) to distinguish the effect of the APOE alleles unambiguously. Hence, data from 5,608 participants were available for the analyses.
###end p 16
###begin p 17
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 335 339 335 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 651 653 651 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">31</xref>
###xml 655 657 655 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">32</xref>
###xml 812 816 812 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 953 955 953 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">33</xref>
Differences in baseline characteristics by APOE genotypes were tested using the chi-squared statistic (categorical variables) or ANOVA (continuous variables). P for trend was obtained by testing the linearity of the sum of squares from the ANOVA analyses. Multiple linear regression analysis was used to assess the interaction between APOE genotype and BMI on total serum cholesterol and HDL-cholesterol levels. Differences in survival probabilities were examined by comparing Kaplan-Meier survival curves and tested using the log rank test. Kaplan-Meier plots were constructed using age as the time scale to take proper account of the effect of age [31, 32]. Risks of mortality were quantified as hazard ratios (HRs) using Cox proportional hazards analyses with age as the time scale. The most common genotype (APOE 3/3) was used as the reference category. The proportionality assumption of all models was verified by testing the Schoenfeld residuals [33]. Because the proportionality assumption was not met, HRs were calculated for early and late mortality using 80 years as the cut-off age. This cut-off age was selected because it led to proportionality of the models below and above the cut-off age. HRs were calculated adjusted for gender, smoking status, education level, total serum cholesterol, HDL-cholesterol, waist to hip ratio hypertension and diabetes mellitus.
###end p 17
###begin title 18
Results
###end title 18
###begin p 19
###xml 179 184 179 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 196 201 196 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 219 224 219 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 258 259 258 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 402 407 402 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 442 447 442 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 575 580 575 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 637 638 635 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 644 649 642 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 689 690 685 686 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 781 788 777 784 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 816 820 812 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 788 836 784 832 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="20">Baseline characteristics by <italic>APOE</italic> genotype groups</p>
###xml 788 836 784 832 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="20">Baseline characteristics by <italic>APOE</italic> genotype groups</p></caption>
###xml 836 836 832 832 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 836 840 832 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 836 851 832 847 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>APOE</italic>*2 carriers</th>
###xml 851 855 847 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 851 859 847 855 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>APOE</italic> 3/3</th>
###xml 859 863 855 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 859 874 855 870 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>APOE</italic>*4 carriers</th>
###xml 874 875 870 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 874 875 870 871 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>p</italic></th>
###xml 836 875 832 871 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left"/><th align="left"><italic>APOE</italic>*2 carriers</th><th align="left"><italic>APOE</italic> 3/3</th><th align="left"><italic>APOE</italic>*4 carriers</th><th align="left"><italic>p</italic></th></tr>
###xml 875 876 871 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 875 876 871 872 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>n</italic></th>
###xml 876 879 872 875 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">782</th>
###xml 879 884 875 880 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3,369</th>
###xml 884 889 880 885 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1,457</th>
###xml 889 889 885 885 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 875 889 871 885 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left"><italic>n</italic></th><th align="left">782</th><th align="left">3,369</th><th align="left">1,457</th><th align="left"/></tr>
###xml 836 889 832 885 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left"/><th align="left"><italic>APOE</italic>*2 carriers</th><th align="left"><italic>APOE</italic> 3/3</th><th align="left"><italic>APOE</italic>*4 carriers</th><th align="left"><italic>p</italic></th></tr><tr><th align="left"><italic>n</italic></th><th align="left">782</th><th align="left">3,369</th><th align="left">1,457</th><th align="left"/></tr></thead>
###xml 889 898 885 894 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Sex (men)</td>
###xml 898 900 894 896 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">38</td>
###xml 900 902 896 898 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">42</td>
###xml 902 904 898 900 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">42</td>
###xml 904 908 900 904 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.05</td>
###xml 889 908 885 904 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Sex (men)</td><td align="left">38</td><td align="left">42</td><td align="left">42</td><td char="." align="char">0.05</td></tr>
###xml 908 928 904 924 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Age at entry (years)</td>
###xml 928 938 924 934 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">68.8 (8.8)</td>
###xml 938 948 934 944 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">68.9 (8.7)</td>
###xml 948 958 944 954 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">68.3 (8.5)</td>
###xml 958 962 954 958 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.14</td>
###xml 908 962 904 958 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Age at entry (years)</td><td align="left">68.8 (8.8)</td><td align="left">68.9 (8.7)</td><td align="left">68.3 (8.5)</td><td char="." align="char">0.14</td></tr>
###xml 983 984 979 980 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 962 985 958 981 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Body mass index (kg/m<sup>2</sup>)</td>
###xml 985 995 981 991 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">26.7 (3.6)</td>
###xml 995 1005 991 1001 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">26.4 (3.6)</td>
###xml 1005 1015 1001 1011 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">26.1 (3.4)</td>
###xml 1015 1020 1011 1016 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&lt;0.01</td>
###xml 962 1020 958 1016 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Body mass index (kg/m<sup>2</sup>)</td><td align="left">26.7 (3.6)</td><td align="left">26.4 (3.6)</td><td align="left">26.1 (3.4)</td><td char="." align="char">&lt;0.01</td></tr>
###xml 1020 1033 1016 1029 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Normal weight</td>
###xml 1033 1035 1029 1031 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">34</td>
###xml 1035 1037 1031 1033 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">39</td>
###xml 1037 1039 1033 1035 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">40</td>
###xml 1039 1039 1035 1035 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 1020 1039 1016 1035 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Normal weight</td><td align="left">34</td><td align="left">39</td><td align="left">40</td><td char="." align="char"/></tr>
###xml 1039 1049 1035 1045 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Overweight</td>
###xml 1049 1051 1045 1047 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">49</td>
###xml 1051 1053 1047 1049 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">47</td>
###xml 1053 1055 1049 1051 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">47</td>
###xml 1055 1060 1051 1056 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&lt;0.05</td>
###xml 1039 1060 1035 1056 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Overweight</td><td align="left">49</td><td align="left">47</td><td align="left">47</td><td char="." align="char">&lt;0.05</td></tr>
###xml 1060 1065 1056 1061 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Obese</td>
###xml 1065 1067 1061 1063 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">17</td>
###xml 1067 1069 1063 1065 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">14</td>
###xml 1069 1071 1065 1067 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">13</td>
###xml 1071 1071 1067 1067 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 1060 1071 1056 1067 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Obese</td><td align="left">17</td><td align="left">14</td><td align="left">13</td><td char="." align="char"/></tr>
###xml 1071 1089 1067 1085 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Waist-to-hip ratio</td>
###xml 1089 1098 1085 1094 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.9 (0.1)</td>
###xml 1098 1107 1094 1103 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.9 (0.1)</td>
###xml 1107 1116 1103 1112 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.9 (0.1)</td>
###xml 1116 1120 1112 1116 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.18</td>
###xml 1071 1120 1067 1116 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Waist-to-hip ratio</td><td align="left">0.9 (0.1)</td><td align="left">0.9 (0.1)</td><td align="left">0.9 (0.1)</td><td char="." align="char">0.18</td></tr>
###xml 1120 1150 1116 1146 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Systolic blood pressure (mmHg)</td>
###xml 1150 1158 1146 1154 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">140 (22)</td>
###xml 1158 1166 1154 1162 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">140 (23)</td>
###xml 1166 1173 1162 1169 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">138 (2)</td>
###xml 1173 1177 1169 1173 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.04</td>
###xml 1120 1177 1116 1173 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Systolic blood pressure (mmHg)</td><td align="left">140 (22)</td><td align="left">140 (23)</td><td align="left">138 (2)</td><td char="." align="char">0.04</td></tr>
###xml 1177 1208 1173 1204 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Diastolic blood pressure (mmHg)</td>
###xml 1208 1215 1204 1211 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">74 (11)</td>
###xml 1215 1222 1211 1218 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">74 (12)</td>
###xml 1222 1229 1218 1225 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">73 (11)</td>
###xml 1229 1233 1225 1229 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.06</td>
###xml 1177 1233 1173 1229 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Diastolic blood pressure (mmHg)</td><td align="left">74 (11)</td><td align="left">74 (12)</td><td align="left">73 (11)</td><td char="." align="char">0.06</td></tr>
###xml 1233 1245 1229 1241 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Hypertension</td>
###xml 1245 1247 1241 1243 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">36</td>
###xml 1247 1249 1243 1245 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">34</td>
###xml 1249 1251 1245 1247 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">33</td>
###xml 1251 1255 1247 1251 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.25</td>
###xml 1233 1255 1229 1251 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Hypertension</td><td align="left">36</td><td align="left">34</td><td align="left">33</td><td char="." align="char">0.25</td></tr>
###xml 1255 1287 1251 1283 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Total serum cholesterol (mmol/l)</td>
###xml 1287 1296 1283 1292 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">6.4 (1.3)</td>
###xml 1296 1305 1292 1301 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">6.6 (1.2)</td>
###xml 1305 1314 1301 1310 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">6.8 (1.2)</td>
###xml 1314 1320 1310 1316 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&lt;0.001</td>
###xml 1255 1320 1251 1316 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Total serum cholesterol (mmol/l)</td><td align="left">6.4 (1.3)</td><td align="left">6.6 (1.2)</td><td align="left">6.8 (1.2)</td><td char="." align="char">&lt;0.001</td></tr>
###xml 1320 1344 1316 1340 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">HDL-cholesterol (mmol/l)</td>
###xml 1344 1353 1340 1349 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.4 (0.4)</td>
###xml 1353 1362 1349 1358 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.3 (0.3)</td>
###xml 1362 1371 1358 1367 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.3 (0.4)</td>
###xml 1371 1377 1367 1373 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&lt;0.001</td>
###xml 1320 1377 1316 1373 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">HDL-cholesterol (mmol/l)</td><td align="left">1.4 (0.4)</td><td align="left">1.3 (0.3)</td><td align="left">1.3 (0.4)</td><td char="." align="char">&lt;0.001</td></tr>
###xml 1377 1408 1373 1404 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Cholesterol lowering medication</td>
###xml 1408 1409 1404 1405 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3</td>
###xml 1409 1410 1405 1406 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">2</td>
###xml 1410 1411 1406 1407 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3</td>
###xml 1411 1415 1407 1411 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.71</td>
###xml 1377 1415 1373 1411 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Cholesterol lowering medication</td><td align="left">3</td><td align="left">2</td><td align="left">3</td><td char="." align="char">0.71</td></tr>
###xml 1415 1435 1411 1431 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Hypercholesterolemia</td>
###xml 1435 1437 1431 1433 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">49</td>
###xml 1437 1439 1433 1435 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">60</td>
###xml 1439 1441 1435 1437 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">66</td>
###xml 1441 1447 1437 1443 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&lt;0.001</td>
###xml 1415 1447 1411 1443 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Hypercholesterolemia</td><td align="left">49</td><td align="left">60</td><td align="left">66</td><td char="." align="char">&lt;0.001</td></tr>
###xml 1447 1471 1443 1467 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Smoking status (current)</td>
###xml 1471 1473 1467 1469 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">39</td>
###xml 1473 1475 1469 1471 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">35</td>
###xml 1475 1477 1471 1473 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">33</td>
###xml 1477 1481 1473 1477 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.02</td>
###xml 1447 1481 1443 1477 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Smoking status (current)</td><td align="left">39</td><td align="left">35</td><td align="left">33</td><td char="." align="char">0.02</td></tr>
###xml 1481 1496 1477 1492 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="5">Education level</td>
###xml 1481 1496 1477 1492 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="5">Education level</td></tr>
###xml 1496 1505 1492 1501 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;&#160;&#160;Lower</td>
###xml 1505 1507 1501 1503 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">43</td>
###xml 1507 1509 1503 1505 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">43</td>
###xml 1509 1511 1505 1507 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">45</td>
###xml 1511 1511 1507 1507 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 1496 1511 1492 1507 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;&#160;&#160;Lower</td><td align="left">43</td><td align="left">43</td><td align="left">45</td><td char="." align="char"/></tr>
###xml 1511 1527 1507 1523 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;&#160;&#160;Intermediate</td>
###xml 1527 1529 1523 1525 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">43</td>
###xml 1529 1531 1525 1527 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">42</td>
###xml 1531 1533 1527 1529 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">40</td>
###xml 1533 1537 1529 1533 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.21</td>
###xml 1511 1537 1507 1533 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;&#160;&#160;Intermediate</td><td align="left">43</td><td align="left">42</td><td align="left">40</td><td char="." align="char">0.21</td></tr>
###xml 1537 1547 1533 1543 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;&#160;&#160;Higher</td>
###xml 1547 1549 1543 1545 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">14</td>
###xml 1549 1551 1545 1547 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">15</td>
###xml 1551 1553 1547 1549 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">15</td>
###xml 1553 1553 1549 1549 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 1537 1553 1533 1549 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;&#160;&#160;Higher</td><td align="left">14</td><td align="left">15</td><td align="left">15</td><td char="." align="char"/></tr>
###xml 1553 1570 1549 1566 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Diabetes mellitus</td>
###xml 1570 1572 1566 1568 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">10</td>
###xml 1572 1574 1568 1570 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">10</td>
###xml 1574 1575 1570 1571 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">9</td>
###xml 1575 1579 1571 1575 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.75</td>
###xml 1553 1579 1549 1575 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Diabetes mellitus</td><td align="left">10</td><td align="left">10</td><td align="left">9</td><td char="." align="char">0.75</td></tr>
###xml 889 1579 885 1575 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">Sex (men)</td><td align="left">38</td><td align="left">42</td><td align="left">42</td><td char="." align="char">0.05</td></tr><tr><td align="left">Age at entry (years)</td><td align="left">68.8 (8.8)</td><td align="left">68.9 (8.7)</td><td align="left">68.3 (8.5)</td><td char="." align="char">0.14</td></tr><tr><td align="left">Body mass index (kg/m<sup>2</sup>)</td><td align="left">26.7 (3.6)</td><td align="left">26.4 (3.6)</td><td align="left">26.1 (3.4)</td><td char="." align="char">&lt;0.01</td></tr><tr><td align="left">Normal weight</td><td align="left">34</td><td align="left">39</td><td align="left">40</td><td char="." align="char"/></tr><tr><td align="left">Overweight</td><td align="left">49</td><td align="left">47</td><td align="left">47</td><td char="." align="char">&lt;0.05</td></tr><tr><td align="left">Obese</td><td align="left">17</td><td align="left">14</td><td align="left">13</td><td char="." align="char"/></tr><tr><td align="left">Waist-to-hip ratio</td><td align="left">0.9 (0.1)</td><td align="left">0.9 (0.1)</td><td align="left">0.9 (0.1)</td><td char="." align="char">0.18</td></tr><tr><td align="left">Systolic blood pressure (mmHg)</td><td align="left">140 (22)</td><td align="left">140 (23)</td><td align="left">138 (2)</td><td char="." align="char">0.04</td></tr><tr><td align="left">Diastolic blood pressure (mmHg)</td><td align="left">74 (11)</td><td align="left">74 (12)</td><td align="left">73 (11)</td><td char="." align="char">0.06</td></tr><tr><td align="left">Hypertension</td><td align="left">36</td><td align="left">34</td><td align="left">33</td><td char="." align="char">0.25</td></tr><tr><td align="left">Total serum cholesterol (mmol/l)</td><td align="left">6.4 (1.3)</td><td align="left">6.6 (1.2)</td><td align="left">6.8 (1.2)</td><td char="." align="char">&lt;0.001</td></tr><tr><td align="left">HDL-cholesterol (mmol/l)</td><td align="left">1.4 (0.4)</td><td align="left">1.3 (0.3)</td><td align="left">1.3 (0.4)</td><td char="." align="char">&lt;0.001</td></tr><tr><td align="left">Cholesterol lowering medication</td><td align="left">3</td><td align="left">2</td><td align="left">3</td><td char="." align="char">0.71</td></tr><tr><td align="left">Hypercholesterolemia</td><td align="left">49</td><td align="left">60</td><td align="left">66</td><td char="." align="char">&lt;0.001</td></tr><tr><td align="left">Smoking status (current)</td><td align="left">39</td><td align="left">35</td><td align="left">33</td><td char="." align="char">0.02</td></tr><tr><td align="left" colspan="5">Education level</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Lower</td><td align="left">43</td><td align="left">43</td><td align="left">45</td><td char="." align="char"/></tr><tr><td align="left">&#160;&#160;&#160;&#160;Intermediate</td><td align="left">43</td><td align="left">42</td><td align="left">40</td><td char="." align="char">0.21</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Higher</td><td align="left">14</td><td align="left">15</td><td align="left">15</td><td char="." align="char"/></tr><tr><td align="left">Diabetes mellitus</td><td align="left">10</td><td align="left">10</td><td align="left">9</td><td char="." align="char">0.75</td></tr></tbody>
###xml 836 1579 832 1575 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left"><italic>APOE</italic>*2 carriers</th><th align="left"><italic>APOE</italic> 3/3</th><th align="left"><italic>APOE</italic>*4 carriers</th><th align="left"><italic>p</italic></th></tr><tr><th align="left"><italic>n</italic></th><th align="left">782</th><th align="left">3,369</th><th align="left">1,457</th><th align="left"/></tr></thead><tbody><tr><td align="left">Sex (men)</td><td align="left">38</td><td align="left">42</td><td align="left">42</td><td char="." align="char">0.05</td></tr><tr><td align="left">Age at entry (years)</td><td align="left">68.8 (8.8)</td><td align="left">68.9 (8.7)</td><td align="left">68.3 (8.5)</td><td char="." align="char">0.14</td></tr><tr><td align="left">Body mass index (kg/m<sup>2</sup>)</td><td align="left">26.7 (3.6)</td><td align="left">26.4 (3.6)</td><td align="left">26.1 (3.4)</td><td char="." align="char">&lt;0.01</td></tr><tr><td align="left">Normal weight</td><td align="left">34</td><td align="left">39</td><td align="left">40</td><td char="." align="char"/></tr><tr><td align="left">Overweight</td><td align="left">49</td><td align="left">47</td><td align="left">47</td><td char="." align="char">&lt;0.05</td></tr><tr><td align="left">Obese</td><td align="left">17</td><td align="left">14</td><td align="left">13</td><td char="." align="char"/></tr><tr><td align="left">Waist-to-hip ratio</td><td align="left">0.9 (0.1)</td><td align="left">0.9 (0.1)</td><td align="left">0.9 (0.1)</td><td char="." align="char">0.18</td></tr><tr><td align="left">Systolic blood pressure (mmHg)</td><td align="left">140 (22)</td><td align="left">140 (23)</td><td align="left">138 (2)</td><td char="." align="char">0.04</td></tr><tr><td align="left">Diastolic blood pressure (mmHg)</td><td align="left">74 (11)</td><td align="left">74 (12)</td><td align="left">73 (11)</td><td char="." align="char">0.06</td></tr><tr><td align="left">Hypertension</td><td align="left">36</td><td align="left">34</td><td align="left">33</td><td char="." align="char">0.25</td></tr><tr><td align="left">Total serum cholesterol (mmol/l)</td><td align="left">6.4 (1.3)</td><td align="left">6.6 (1.2)</td><td align="left">6.8 (1.2)</td><td char="." align="char">&lt;0.001</td></tr><tr><td align="left">HDL-cholesterol (mmol/l)</td><td align="left">1.4 (0.4)</td><td align="left">1.3 (0.3)</td><td align="left">1.3 (0.4)</td><td char="." align="char">&lt;0.001</td></tr><tr><td align="left">Cholesterol lowering medication</td><td align="left">3</td><td align="left">2</td><td align="left">3</td><td char="." align="char">0.71</td></tr><tr><td align="left">Hypercholesterolemia</td><td align="left">49</td><td align="left">60</td><td align="left">66</td><td char="." align="char">&lt;0.001</td></tr><tr><td align="left">Smoking status (current)</td><td align="left">39</td><td align="left">35</td><td align="left">33</td><td char="." align="char">0.02</td></tr><tr><td align="left" colspan="5">Education level</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Lower</td><td align="left">43</td><td align="left">43</td><td align="left">45</td><td char="." align="char"/></tr><tr><td align="left">&#160;&#160;&#160;&#160;Intermediate</td><td align="left">43</td><td align="left">42</td><td align="left">40</td><td char="." align="char">0.21</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Higher</td><td align="left">14</td><td align="left">15</td><td align="left">15</td><td char="." align="char"/></tr><tr><td align="left">Diabetes mellitus</td><td align="left">10</td><td align="left">10</td><td align="left">9</td><td char="." align="char">0.75</td></tr></tbody></table>
###xml 1686 1687 1682 1683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1752 1753 1746 1747 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1579 1779 1575 1773 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="21">Values are means (standard deviations) for continuous variables and percentages for categorical variables. <italic>p</italic> values are obtained by ANOVA for continuous variables and by &#967;<sup>2</sup> for categorical variables</p>
###xml 1579 1779 1575 1773 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="21">Values are means (standard deviations) for continuous variables and percentages for categorical variables. <italic>p</italic> values are obtained by ANOVA for continuous variables and by &#967;<sup>2</sup> for categorical variables</p></table-wrap-foot>
###xml 781 1779 777 1773 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="20">Baseline characteristics by <italic>APOE</italic> genotype groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left"><italic>APOE</italic>*2 carriers</th><th align="left"><italic>APOE</italic> 3/3</th><th align="left"><italic>APOE</italic>*4 carriers</th><th align="left"><italic>p</italic></th></tr><tr><th align="left"><italic>n</italic></th><th align="left">782</th><th align="left">3,369</th><th align="left">1,457</th><th align="left"/></tr></thead><tbody><tr><td align="left">Sex (men)</td><td align="left">38</td><td align="left">42</td><td align="left">42</td><td char="." align="char">0.05</td></tr><tr><td align="left">Age at entry (years)</td><td align="left">68.8 (8.8)</td><td align="left">68.9 (8.7)</td><td align="left">68.3 (8.5)</td><td char="." align="char">0.14</td></tr><tr><td align="left">Body mass index (kg/m<sup>2</sup>)</td><td align="left">26.7 (3.6)</td><td align="left">26.4 (3.6)</td><td align="left">26.1 (3.4)</td><td char="." align="char">&lt;0.01</td></tr><tr><td align="left">Normal weight</td><td align="left">34</td><td align="left">39</td><td align="left">40</td><td char="." align="char"/></tr><tr><td align="left">Overweight</td><td align="left">49</td><td align="left">47</td><td align="left">47</td><td char="." align="char">&lt;0.05</td></tr><tr><td align="left">Obese</td><td align="left">17</td><td align="left">14</td><td align="left">13</td><td char="." align="char"/></tr><tr><td align="left">Waist-to-hip ratio</td><td align="left">0.9 (0.1)</td><td align="left">0.9 (0.1)</td><td align="left">0.9 (0.1)</td><td char="." align="char">0.18</td></tr><tr><td align="left">Systolic blood pressure (mmHg)</td><td align="left">140 (22)</td><td align="left">140 (23)</td><td align="left">138 (2)</td><td char="." align="char">0.04</td></tr><tr><td align="left">Diastolic blood pressure (mmHg)</td><td align="left">74 (11)</td><td align="left">74 (12)</td><td align="left">73 (11)</td><td char="." align="char">0.06</td></tr><tr><td align="left">Hypertension</td><td align="left">36</td><td align="left">34</td><td align="left">33</td><td char="." align="char">0.25</td></tr><tr><td align="left">Total serum cholesterol (mmol/l)</td><td align="left">6.4 (1.3)</td><td align="left">6.6 (1.2)</td><td align="left">6.8 (1.2)</td><td char="." align="char">&lt;0.001</td></tr><tr><td align="left">HDL-cholesterol (mmol/l)</td><td align="left">1.4 (0.4)</td><td align="left">1.3 (0.3)</td><td align="left">1.3 (0.4)</td><td char="." align="char">&lt;0.001</td></tr><tr><td align="left">Cholesterol lowering medication</td><td align="left">3</td><td align="left">2</td><td align="left">3</td><td char="." align="char">0.71</td></tr><tr><td align="left">Hypercholesterolemia</td><td align="left">49</td><td align="left">60</td><td align="left">66</td><td char="." align="char">&lt;0.001</td></tr><tr><td align="left">Smoking status (current)</td><td align="left">39</td><td align="left">35</td><td align="left">33</td><td char="." align="char">0.02</td></tr><tr><td align="left" colspan="5">Education level</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Lower</td><td align="left">43</td><td align="left">43</td><td align="left">45</td><td char="." align="char"/></tr><tr><td align="left">&#160;&#160;&#160;&#160;Intermediate</td><td align="left">43</td><td align="left">42</td><td align="left">40</td><td char="." align="char">0.21</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Higher</td><td align="left">14</td><td align="left">15</td><td align="left">15</td><td char="." align="char"/></tr><tr><td align="left">Diabetes mellitus</td><td align="left">10</td><td align="left">10</td><td align="left">9</td><td char="." align="char">0.75</td></tr></tbody></table><table-wrap-foot><p textid="21">Values are means (standard deviations) for continuous variables and percentages for categorical variables. <italic>p</italic> values are obtained by ANOVA for continuous variables and by &#967;<sup>2</sup> for categorical variables</p></table-wrap-foot></table-wrap>
###xml 71 83 <span type="species:ncbi:9606">participants</span>
###xml 89 92 <span type="species:ncbi:9606">men</span>
###xml 894 897 <span type="species:ncbi:9606">men</span>
The mean age at entry was 68.7 years (SD = 8.7 years) and 41.8% of the participants were men. The mean follow up time was 11.1 years (SD = 3.8 years). Baseline characteristics of APOE*2 carriers, APOE*3 homozygotes and APOE*4 carriers are presented in Table 1. As expected, cholesterol levels differed significantly between the genotype groups. The prevalence of hypercholesterolaemia was lowest among APOE*2 carriers (49%) and highest among APOE*4 carriers (66%). Furthermore, there were statistically significant differences in BMI scores between the genotype groups, with APOE*2 carriers having the highest mean BMI (26.7 +/- 3.6 kg/m2) and APOE*4 carriers the lowest (26.1 +/- 3.4 kg/m2). There were no statistically significant differences in WHR between the genotype groups. Table 1Baseline characteristics by APOE genotype groupsAPOE*2 carriersAPOE 3/3APOE*4 carrierspn7823,3691,457Sex (men)3842420.05Age at entry (years)68.8 (8.8)68.9 (8.7)68.3 (8.5)0.14Body mass index (kg/m2)26.7 (3.6)26.4 (3.6)26.1 (3.4)<0.01Normal weight343940Overweight494747<0.05Obese171413Waist-to-hip ratio0.9 (0.1)0.9 (0.1)0.9 (0.1)0.18Systolic blood pressure (mmHg)140 (22)140 (23)138 (2)0.04Diastolic blood pressure (mmHg)74 (11)74 (12)73 (11)0.06Hypertension3634330.25Total serum cholesterol (mmol/l)6.4 (1.3)6.6 (1.2)6.8 (1.2)<0.001HDL-cholesterol (mmol/l)1.4 (0.4)1.3 (0.3)1.3 (0.4)<0.001Cholesterol lowering medication3230.71Hypercholesterolemia496066<0.001Smoking status (current)3935330.02Education level    Lower434345    Intermediate4342400.21    Higher141515Diabetes mellitus101090.75Values are means (standard deviations) for continuous variables and percentages for categorical variables. p values are obtained by ANOVA for continuous variables and by chi2 for categorical variables
###end p 19
###begin p 20
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
Baseline characteristics by APOE genotype groups
###end p 20
###begin p 21
###xml 107 108 107 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 173 174 171 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
Values are means (standard deviations) for continuous variables and percentages for categorical variables. p values are obtained by ANOVA for continuous variables and by chi2 for categorical variables
###end p 21
###begin p 22
###xml 7 8 7 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 77 81 77 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 158 163 158 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 193 198 193 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 246 247 246 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 247 256 247 256 <sub xmlns:xlink="http://www.w3.org/1999/xlink">for trend</sub>
###xml 310 314 310 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 355 356 355 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 356 365 356 365 <sub xmlns:xlink="http://www.w3.org/1999/xlink">for trend</sub>
###xml 397 402 397 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 527 532 527 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 606 611 606 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 623 624 623 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 693 697 693 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 755 756 755 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 786 787 786 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 860 861 860 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 962 968 962 968 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 1027 1031 1027 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 968 1125 968 1125 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="23">Mean total serum cholesterol and HDL-cholesterol levels by <italic>APOE</italic> genotypes for normal weight, overweight and obese individuals. HDL: high-density lipoproteins</p>
###xml 968 1125 968 1125 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="23">Mean total serum cholesterol and HDL-cholesterol levels by <italic>APOE</italic> genotypes for normal weight, overweight and obese individuals. HDL: high-density lipoproteins</p></caption>
###xml 1125 1125 1125 1125 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="10654_2007_9202_Fig1_HTML" id="MO1"/>
###xml 962 1125 962 1125 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="23">Mean total serum cholesterol and HDL-cholesterol levels by <italic>APOE</italic> genotypes for normal weight, overweight and obese individuals. HDL: high-density lipoproteins</p></caption><graphic position="anchor" xlink:href="10654_2007_9202_Fig1_HTML" id="MO1"/></fig>
###xml 130 137 <span type="species:ncbi:9606">persons</span>
Figure 1 presents mean total serum cholesterol and HDL-cholesterol levels by APOE genotype in normal weight, overweight and obese persons. In all BMI strata, APOE*2 carriers had the lowest and APOE*4 carriers the highest total serum cholesterol (pfor trend < 0.01). The association between HDL-cholesterol and APOE genotype was in the opposite direction (pfor trend < 0.01). Note that even though APOE*2 carriers had the lowest total serum cholesterol levels in each BMI group, still 50% of the overweight and 57% of the obese APOE*2 carriers had hypercholesterolaemia compared to 41% of the normal weight APOE*2 carriers (p = 0.003). There was no significant evidence for interaction between APOE genotype and BMI in relation to total serum cholesterol (p = 0.26) and HDL-cholesterol (p = 0.25). However, when BMI was analyzed as a continuous trait, then the p value for interaction was 0.04 for total serum cholesterol and less than 0.001 for HDL-cholesterol. Fig. 1Mean total serum cholesterol and HDL-cholesterol levels by APOE genotypes for normal weight, overweight and obese individuals. HDL: high-density lipoproteins
###end p 22
###begin p 23
###xml 59 63 59 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
Mean total serum cholesterol and HDL-cholesterol levels by APOE genotypes for normal weight, overweight and obese individuals. HDL: high-density lipoproteins
###end p 23
###begin p 24
###xml 81 86 81 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 119 124 119 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 161 166 161 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 244 249 244 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 261 266 261 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 284 289 284 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 342 343 342 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 357 362 357 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 417 418 417 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 477 481 477 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 600 601 600 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 705 706 705 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 720 721 720 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 754 759 754 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 1055 1056 1055 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 1059 1065 1059 1065 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;2</label>
###xml 1121 1125 1121 1125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 1065 1135 1065 1135 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="25">Kaplan Meier survival curves for all-cause mortality by <italic>APOE</italic> genotypes</p>
###xml 1065 1135 1065 1135 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="25">Kaplan Meier survival curves for all-cause mortality by <italic>APOE</italic> genotypes</p></caption>
###xml 1135 1135 1135 1135 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="10654_2007_9202_Fig2_HTML" id="MO2"/>
###xml 1059 1135 1059 1135 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig2"><label>Fig.&#160;2</label><caption><p textid="25">Kaplan Meier survival curves for all-cause mortality by <italic>APOE</italic> genotypes</p></caption><graphic position="anchor" xlink:href="10654_2007_9202_Fig2_HTML" id="MO2"/></fig>
###xml 1135 1142 1135 1142 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;2</label>
###xml 1203 1207 1203 1207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 1142 1236 1142 1236 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="26">Incidence rates and hazard ratios for all-cause mortality by <italic>APOE</italic> genotypes and BMI categories</p>
###xml 1142 1236 1142 1236 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="26">Incidence rates and hazard ratios for all-cause mortality by <italic>APOE</italic> genotypes and BMI categories</p></caption>
###xml 1236 1236 1236 1236 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="3"/>
###xml 1236 1245 1236 1245 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="2">Follow-up</th>
###xml 1245 1259 1245 1259 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Incidence rate</th>
###xml 1259 1271 1259 1271 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Hazard ratio</th>
###xml 1271 1280 1271 1280 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="2">Follow-up</th>
###xml 1280 1294 1280 1294 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Incidence rate</th>
###xml 1294 1306 1294 1306 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Hazard ratio</th>
###xml 1236 1306 1236 1306 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left" rowspan="3"/><th align="left" colspan="2">Follow-up</th><th align="left">Incidence rate</th><th align="left">Hazard ratio</th><th align="left" colspan="2">Follow-up</th><th align="left">Incidence rate</th><th align="left">Hazard ratio</th></tr>
###xml 1306 1312 1306 1312 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Deaths</th>
###xml 1312 1316 1312 1316 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">(py)</th>
###xml 1316 1340 1316 1340 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Deaths/1,000 py (95% CI)</th>
###xml 1340 1348 1340 1348 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">(95% CI)</th>
###xml 1348 1354 1348 1354 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Deaths</th>
###xml 1354 1358 1354 1358 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">(py)</th>
###xml 1358 1382 1358 1382 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Deaths/1,000 py (95% CI)</th>
###xml 1382 1390 1382 1390 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">(95% CI)</th>
###xml 1306 1390 1306 1390 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Deaths</th><th align="left">(py)</th><th align="left">Deaths/1,000 py (95% CI)</th><th align="left">(95% CI)</th><th align="left">Deaths</th><th align="left">(py)</th><th align="left">Deaths/1,000 py (95% CI)</th><th align="left">(95% CI)</th></tr>
###xml 1390 1412 1390 1412 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="4">Before 80&#160;years of age</th>
###xml 1412 1433 1412 1433 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="4">After 80&#160;years of age</th>
###xml 1390 1433 1390 1433 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left" colspan="4">Before 80&#160;years of age</th><th align="left" colspan="4">After 80&#160;years of age</th></tr>
###xml 1236 1433 1236 1433 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left" rowspan="3"/><th align="left" colspan="2">Follow-up</th><th align="left">Incidence rate</th><th align="left">Hazard ratio</th><th align="left" colspan="2">Follow-up</th><th align="left">Incidence rate</th><th align="left">Hazard ratio</th></tr><tr><th align="left">Deaths</th><th align="left">(py)</th><th align="left">Deaths/1,000 py (95% CI)</th><th align="left">(95% CI)</th><th align="left">Deaths</th><th align="left">(py)</th><th align="left">Deaths/1,000 py (95% CI)</th><th align="left">(95% CI)</th></tr><tr><th align="left" colspan="4">Before 80&#160;years of age</th><th align="left" colspan="4">After 80&#160;years of age</th></tr></thead>
###xml 1433 1436 1433 1436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">All</italic>
###xml 1433 1436 1433 1436 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="9"><italic>All</italic></td>
###xml 1433 1436 1433 1436 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="9"><italic>All</italic></td></tr>
###xml 1436 1451 1436 1451 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">APOE*2 carriers</td>
###xml 1451 1454 1451 1454 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">101</td>
###xml 1454 1459 1454 1459 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">6,782</td>
###xml 1459 1475 1459 1475 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">14.9 (12.3&#8211;18.1)</td>
###xml 1475 1488 1475 1488 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0.9 (0.7&#8211;1.1)</td>
###xml 1488 1491 1488 1491 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">156</td>
###xml 1491 1497 1491 1497 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">21,764</td>
###xml 1497 1510 1497 1510 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">7.2 (6.1&#8211;8.4)</td>
###xml 1510 1523 1510 1523 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0.9 (0.8&#8211;1.1)</td>
###xml 1436 1523 1436 1523 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">APOE*2 carriers</td><td char="." align="char">101</td><td char="." align="char">6,782</td><td char="(" align="char">14.9 (12.3&#8211;18.1)</td><td char="(" align="char">0.9 (0.7&#8211;1.1)</td><td char="." align="char">156</td><td char="." align="char">21,764</td><td char="(" align="char">7.2 (6.1&#8211;8.4)</td><td char="(" align="char">0.9 (0.8&#8211;1.1)</td></tr>
###xml 1523 1531 1523 1531 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">APOE 3/3</td>
###xml 1531 1534 1531 1534 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">481</td>
###xml 1534 1540 1534 1540 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">28,703</td>
###xml 1540 1556 1540 1556 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">16.8 (15.3&#8211;18.3)</td>
###xml 1556 1556 1556 1556 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 1556 1559 1556 1559 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">679</td>
###xml 1559 1565 1559 1565 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">95,808</td>
###xml 1565 1578 1565 1578 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">7.1 (6.6&#8211;7.6)</td>
###xml 1578 1578 1578 1578 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 1523 1578 1523 1578 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">APOE 3/3</td><td char="." align="char">481</td><td char="." align="char">28,703</td><td char="(" align="char">16.8 (15.3&#8211;18.3)</td><td char="(" align="char"/><td char="." align="char">679</td><td char="." align="char">95,808</td><td char="(" align="char">7.1 (6.6&#8211;7.6)</td><td char="(" align="char"/></tr>
###xml 1578 1593 1578 1593 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">APOE*4 carriers</td>
###xml 1593 1596 1593 1596 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">198</td>
###xml 1596 1602 1596 1602 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">12,693</td>
###xml 1602 1618 1602 1618 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">15.6 (13.6&#8211;17.9)</td>
###xml 1618 1631 1618 1631 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1.0 (0.8&#8211;1.2)</td>
###xml 1631 1634 1631 1634 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">303</td>
###xml 1634 1640 1634 1640 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">41,637</td>
###xml 1640 1653 1640 1653 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">7.3 (6.5&#8211;8.1)</td>
###xml 1653 1666 1653 1666 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1.2 (1.0&#8211;1.4)</td>
###xml 1578 1666 1578 1666 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">APOE*4 carriers</td><td char="." align="char">198</td><td char="." align="char">12,693</td><td char="(" align="char">15.6 (13.6&#8211;17.9)</td><td char="(" align="char">1.0 (0.8&#8211;1.2)</td><td char="." align="char">303</td><td char="." align="char">41,637</td><td char="(" align="char">7.3 (6.5&#8211;8.1)</td><td char="(" align="char">1.2 (1.0&#8211;1.4)</td></tr>
###xml 1666 1671 1666 1671 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Total</td>
###xml 1671 1674 1671 1674 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">780</td>
###xml 1674 1680 1674 1680 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">48,178</td>
###xml 1680 1696 1680 1696 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">16.2 (15.1&#8211;17.4)</td>
###xml 1696 1696 1696 1696 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 1696 1701 1696 1701 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1,138</td>
###xml 1701 1708 1701 1708 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">159,209</td>
###xml 1708 1721 1708 1721 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">7.1 (6.7&#8211;7.6)</td>
###xml 1721 1721 1721 1721 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 1666 1721 1666 1721 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Total</td><td char="." align="char">780</td><td char="." align="char">48,178</td><td char="(" align="char">16.2 (15.1&#8211;17.4)</td><td char="(" align="char"/><td char="." align="char">1,138</td><td char="." align="char">159,209</td><td char="(" align="char">7.1 (6.7&#8211;7.6)</td><td char="(" align="char"/></tr>
###xml 1721 1734 1721 1734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Normal weight</italic>
###xml 1721 1734 1721 1734 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="9"><italic>Normal weight</italic></td>
###xml 1721 1734 1721 1734 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="9"><italic>Normal weight</italic></td></tr>
###xml 1734 1749 1734 1749 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">APOE*2 carriers</td>
###xml 1749 1751 1749 1751 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">28</td>
###xml 1751 1756 1751 1756 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2,370</td>
###xml 1756 1771 1756 1771 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">11.8 (8.2&#8211;17.1)</td>
###xml 1771 1784 1771 1784 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0.7 (0.5&#8211;0.9)</td>
###xml 1784 1786 1784 1786 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">57</td>
###xml 1786 1791 1786 1791 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">7,289</td>
###xml 1791 1805 1791 1805 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">7.8 (6.0&#8211;10.1)</td>
###xml 1805 1818 1805 1818 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1.0 (0.8&#8211;1.4)</td>
###xml 1734 1818 1734 1818 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">APOE*2 carriers</td><td char="." align="char">28</td><td char="." align="char">2,370</td><td char="(" align="char">11.8 (8.2&#8211;17.1)</td><td char="(" align="char">0.7 (0.5&#8211;0.9)</td><td char="." align="char">57</td><td char="." align="char">7,289</td><td char="(" align="char">7.8 (6.0&#8211;10.1)</td><td char="(" align="char">1.0 (0.8&#8211;1.4)</td></tr>
###xml 1818 1826 1818 1826 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">APOE 3/3</td>
###xml 1826 1829 1826 1829 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">206</td>
###xml 1829 1835 1829 1835 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">11,314</td>
###xml 1835 1851 1835 1851 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">18.2 (15.9&#8211;20.9)</td>
###xml 1851 1851 1851 1851 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 1851 1854 1851 1854 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">256</td>
###xml 1854 1860 1854 1860 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">38,045</td>
###xml 1860 1873 1860 1873 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">6.7 (6.0&#8211;7.6)</td>
###xml 1873 1873 1873 1873 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 1818 1873 1818 1873 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">APOE 3/3</td><td char="." align="char">206</td><td char="." align="char">11,314</td><td char="(" align="char">18.2 (15.9&#8211;20.9)</td><td char="(" align="char"/><td char="." align="char">256</td><td char="." align="char">38,045</td><td char="(" align="char">6.7 (6.0&#8211;7.6)</td><td char="(" align="char"/></tr>
###xml 1873 1888 1873 1888 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">APOE*4 carriers</td>
###xml 1888 1890 1888 1890 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">78</td>
###xml 1890 1895 1890 1895 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">5,080</td>
###xml 1895 1911 1895 1911 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">15.4 (12.3&#8211;19.2)</td>
###xml 1911 1924 1911 1924 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1.0 (0.7&#8211;1.3)</td>
###xml 1924 1927 1924 1927 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">127</td>
###xml 1927 1933 1927 1933 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">17,305</td>
###xml 1933 1946 1933 1946 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">7.3 (6.2&#8211;8.7)</td>
###xml 1946 1959 1946 1959 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1.3 (0.9&#8211;1.7)</td>
###xml 1873 1959 1873 1959 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">APOE*4 carriers</td><td char="." align="char">78</td><td char="." align="char">5,080</td><td char="(" align="char">15.4 (12.3&#8211;19.2)</td><td char="(" align="char">1.0 (0.7&#8211;1.3)</td><td char="." align="char">127</td><td char="." align="char">17,305</td><td char="(" align="char">7.3 (6.2&#8211;8.7)</td><td char="(" align="char">1.3 (0.9&#8211;1.7)</td></tr>
###xml 1959 1964 1959 1964 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Total</td>
###xml 1964 1967 1964 1967 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">312</td>
###xml 1967 1973 1967 1973 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">18,764</td>
###xml 1973 1989 1973 1989 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">16.6 (14.9&#8211;18.6)</td>
###xml 1989 1989 1989 1989 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 1989 1992 1989 1992 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">440</td>
###xml 1992 1998 1992 1998 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">62,639</td>
###xml 1998 2011 1998 2011 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">7.0 (6.4&#8211;7.7)</td>
###xml 2011 2011 2011 2011 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 1959 2011 1959 2011 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Total</td><td char="." align="char">312</td><td char="." align="char">18,764</td><td char="(" align="char">16.6 (14.9&#8211;18.6)</td><td char="(" align="char"/><td char="." align="char">440</td><td char="." align="char">62,639</td><td char="(" align="char">7.0 (6.4&#8211;7.7)</td><td char="(" align="char"/></tr>
###xml 2011 2021 2011 2021 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Overweight</italic>
###xml 2011 2021 2011 2021 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="9"><italic>Overweight</italic></td>
###xml 2011 2021 2011 2021 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="9"><italic>Overweight</italic></td></tr>
###xml 2021 2036 2021 2036 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">APOE*2 carriers</td>
###xml 2036 2038 2036 2038 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">59</td>
###xml 2038 2043 2038 2043 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3,305</td>
###xml 2043 2059 2043 2059 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">17.9 (13.8&#8211;23.0)</td>
###xml 2059 2072 2059 2072 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1.1 (0.9&#8211;1.5)</td>
###xml 2072 2074 2072 2074 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">65</td>
###xml 2074 2080 2074 2080 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">11,064</td>
###xml 2080 2093 2080 2093 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5.9 (4.6&#8211;7.5)</td>
###xml 2093 2106 2093 2106 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0.9 (0.7&#8211;1.1)</td>
###xml 2021 2106 2021 2106 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">APOE*2 carriers</td><td char="." align="char">59</td><td char="." align="char">3,305</td><td char="(" align="char">17.9 (13.8&#8211;23.0)</td><td char="(" align="char">1.1 (0.9&#8211;1.5)</td><td char="." align="char">65</td><td char="." align="char">11,064</td><td char="(" align="char">5.9 (4.6&#8211;7.5)</td><td char="(" align="char">0.9 (0.7&#8211;1.1)</td></tr>
###xml 2106 2114 2106 2114 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">APOE 3/3</td>
###xml 2114 2117 2114 2117 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">217</td>
###xml 2117 2123 2117 2123 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">13,573</td>
###xml 2123 2139 2123 2139 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">16.0 (14.0&#8211;18.3)</td>
###xml 2139 2139 2139 2139 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 2139 2142 2139 2142 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">310</td>
###xml 2142 2148 2142 2148 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">45,366</td>
###xml 2148 2161 2148 2161 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">6.8 (6.1&#8211;7.6)</td>
###xml 2161 2161 2161 2161 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 2106 2161 2106 2161 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">APOE 3/3</td><td char="." align="char">217</td><td char="." align="char">13,573</td><td char="(" align="char">16.0 (14.0&#8211;18.3)</td><td align="left"/><td char="." align="char">310</td><td char="." align="char">45,366</td><td char="(" align="char">6.8 (6.1&#8211;7.6)</td><td char="(" align="char"/></tr>
###xml 2161 2176 2161 2176 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">APOE*4 carriers</td>
###xml 2176 2178 2176 2178 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">90</td>
###xml 2178 2183 2178 2183 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">6,047</td>
###xml 2183 2199 2183 2199 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">14.9 (12.1&#8211;18.3)</td>
###xml 2199 2212 2199 2212 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0.9 (0.7&#8211;1.2)</td>
###xml 2212 2215 2212 2215 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">137</td>
###xml 2215 2221 2215 2221 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">19,398</td>
###xml 2221 2234 2221 2234 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">7.1 (6.0&#8211;8.4)</td>
###xml 2234 2247 2234 2247 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1.2 (1.0&#8211;1.5)</td>
###xml 2161 2247 2161 2247 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">APOE*4 carriers</td><td char="." align="char">90</td><td char="." align="char">6,047</td><td char="(" align="char">14.9 (12.1&#8211;18.3)</td><td char="(" align="char">0.9 (0.7&#8211;1.2)</td><td char="." align="char">137</td><td char="." align="char">19,398</td><td char="(" align="char">7.1 (6.0&#8211;8.4)</td><td char="(" align="char">1.2 (1.0&#8211;1.5)</td></tr>
###xml 2247 2252 2247 2252 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Total</td>
###xml 2252 2255 2252 2255 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">366</td>
###xml 2255 2261 2255 2261 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">22,924</td>
###xml 2261 2277 2261 2277 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">16.0 (14.4&#8211;17.7)</td>
###xml 2277 2277 2277 2277 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 2277 2280 2277 2280 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">512</td>
###xml 2280 2286 2280 2286 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">75,827</td>
###xml 2286 2299 2286 2299 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">6.8 (6.2&#8211;7.4)</td>
###xml 2299 2299 2299 2299 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 2247 2299 2247 2299 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Total</td><td char="." align="char">366</td><td char="." align="char">22,924</td><td char="(" align="char">16.0 (14.4&#8211;17.7)</td><td char="(" align="char"/><td char="." align="char">512</td><td char="." align="char">75,827</td><td char="(" align="char">6.8 (6.2&#8211;7.4)</td><td char="(" align="char"/></tr>
###xml 2299 2304 2299 2304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Obese</italic>
###xml 2299 2304 2299 2304 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="9"><italic>Obese</italic></td>
###xml 2299 2304 2299 2304 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="9"><italic>Obese</italic></td></tr>
###xml 2304 2319 2304 2319 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">APOE*2 carriers</td>
###xml 2319 2321 2319 2321 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">14</td>
###xml 2321 2326 2321 2326 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1,107</td>
###xml 2326 2341 2326 2341 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">12.6 (7.5&#8211;21.4)</td>
###xml 2341 2354 2341 2354 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1.0 (0.5&#8211;1.8)</td>
###xml 2354 2356 2354 2356 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">34</td>
###xml 2356 2361 2356 2361 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3,411</td>
###xml 2361 2376 2361 2376 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">10.0 (7.1&#8211;14.0)</td>
###xml 2376 2389 2376 2389 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1.0 (0.6&#8211;1.5)</td>
###xml 2304 2389 2304 2389 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">APOE*2 carriers</td><td char="." align="char">14</td><td char="." align="char">1,107</td><td char="(" align="char">12.6 (7.5&#8211;21.4)</td><td char="(" align="char">1.0 (0.5&#8211;1.8)</td><td char="." align="char">34</td><td char="." align="char">3,411</td><td char="(" align="char">10.0 (7.1&#8211;14.0)</td><td char="(" align="char">1.0 (0.6&#8211;1.5)</td></tr>
###xml 2389 2397 2389 2397 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">APOE 3/3</td>
###xml 2397 2399 2397 2399 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">58</td>
###xml 2399 2404 2399 2404 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3,816</td>
###xml 2404 2420 2404 2420 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">15.2 (11.7&#8211;19.7)</td>
###xml 2420 2420 2420 2420 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 2420 2423 2420 2423 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">113</td>
###xml 2423 2429 2423 2429 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">12,398</td>
###xml 2429 2443 2429 2443 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">9.1 (7.6&#8211;11.0)</td>
###xml 2443 2443 2443 2443 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 2389 2443 2389 2443 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">APOE 3/3</td><td char="." align="char">58</td><td char="." align="char">3,816</td><td char="(" align="char">15.2 (11.7&#8211;19.7)</td><td char="(" align="char"/><td char="." align="char">113</td><td char="." align="char">12,398</td><td char="(" align="char">9.1 (7.6&#8211;11.0)</td><td char="(" align="char"/></tr>
###xml 2443 2458 2443 2458 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">APOE*4 carriers</td>
###xml 2458 2460 2458 2460 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">30</td>
###xml 2460 2465 2460 2465 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1,566</td>
###xml 2465 2481 2465 2481 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">19.2 (13.4&#8211;27.4)</td>
###xml 2481 2494 2481 2494 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1.3 (0.9&#8211;2.0)</td>
###xml 2494 2496 2494 2496 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">39</td>
###xml 2496 2501 2496 2501 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">4,934</td>
###xml 2501 2515 2501 2515 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">7.9 (5.8&#8211;10.8)</td>
###xml 2515 2528 2515 2528 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1.1 (0.8&#8211;1.6)</td>
###xml 2443 2528 2443 2528 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">APOE*4 carriers</td><td char="." align="char">30</td><td char="." align="char">1,566</td><td char="(" align="char">19.2 (13.4&#8211;27.4)</td><td char="(" align="char">1.3 (0.9&#8211;2.0)</td><td char="." align="char">39</td><td char="." align="char">4,934</td><td char="(" align="char">7.9 (5.8&#8211;10.8)</td><td char="(" align="char">1.1 (0.8&#8211;1.6)</td></tr>
###xml 2528 2533 2528 2533 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Total</td>
###xml 2533 2536 2533 2536 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">102</td>
###xml 2536 2541 2536 2541 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">6,489</td>
###xml 2541 2557 2541 2557 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">15.7 (12.9&#8211;19.1)</td>
###xml 2557 2557 2557 2557 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 2557 2560 2557 2560 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">186</td>
###xml 2560 2566 2560 2566 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">20,742</td>
###xml 2566 2580 2566 2580 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">9.0 (7.8&#8211;10.4)</td>
###xml 2580 2580 2580 2580 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 2528 2580 2528 2580 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Total</td><td char="." align="char">102</td><td char="." align="char">6,489</td><td char="(" align="char">15.7 (12.9&#8211;19.1)</td><td char="(" align="char"/><td char="." align="char">186</td><td char="." align="char">20,742</td><td char="(" align="char">9.0 (7.8&#8211;10.4)</td><td char="(" align="char"/></tr>
###xml 1433 2580 1433 2580 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left" colspan="9"><italic>All</italic></td></tr><tr><td align="left">APOE*2 carriers</td><td char="." align="char">101</td><td char="." align="char">6,782</td><td char="(" align="char">14.9 (12.3&#8211;18.1)</td><td char="(" align="char">0.9 (0.7&#8211;1.1)</td><td char="." align="char">156</td><td char="." align="char">21,764</td><td char="(" align="char">7.2 (6.1&#8211;8.4)</td><td char="(" align="char">0.9 (0.8&#8211;1.1)</td></tr><tr><td align="left">APOE 3/3</td><td char="." align="char">481</td><td char="." align="char">28,703</td><td char="(" align="char">16.8 (15.3&#8211;18.3)</td><td char="(" align="char"/><td char="." align="char">679</td><td char="." align="char">95,808</td><td char="(" align="char">7.1 (6.6&#8211;7.6)</td><td char="(" align="char"/></tr><tr><td align="left">APOE*4 carriers</td><td char="." align="char">198</td><td char="." align="char">12,693</td><td char="(" align="char">15.6 (13.6&#8211;17.9)</td><td char="(" align="char">1.0 (0.8&#8211;1.2)</td><td char="." align="char">303</td><td char="." align="char">41,637</td><td char="(" align="char">7.3 (6.5&#8211;8.1)</td><td char="(" align="char">1.2 (1.0&#8211;1.4)</td></tr><tr><td align="left">Total</td><td char="." align="char">780</td><td char="." align="char">48,178</td><td char="(" align="char">16.2 (15.1&#8211;17.4)</td><td char="(" align="char"/><td char="." align="char">1,138</td><td char="." align="char">159,209</td><td char="(" align="char">7.1 (6.7&#8211;7.6)</td><td char="(" align="char"/></tr><tr><td align="left" colspan="9"><italic>Normal weight</italic></td></tr><tr><td align="left">APOE*2 carriers</td><td char="." align="char">28</td><td char="." align="char">2,370</td><td char="(" align="char">11.8 (8.2&#8211;17.1)</td><td char="(" align="char">0.7 (0.5&#8211;0.9)</td><td char="." align="char">57</td><td char="." align="char">7,289</td><td char="(" align="char">7.8 (6.0&#8211;10.1)</td><td char="(" align="char">1.0 (0.8&#8211;1.4)</td></tr><tr><td align="left">APOE 3/3</td><td char="." align="char">206</td><td char="." align="char">11,314</td><td char="(" align="char">18.2 (15.9&#8211;20.9)</td><td char="(" align="char"/><td char="." align="char">256</td><td char="." align="char">38,045</td><td char="(" align="char">6.7 (6.0&#8211;7.6)</td><td char="(" align="char"/></tr><tr><td align="left">APOE*4 carriers</td><td char="." align="char">78</td><td char="." align="char">5,080</td><td char="(" align="char">15.4 (12.3&#8211;19.2)</td><td char="(" align="char">1.0 (0.7&#8211;1.3)</td><td char="." align="char">127</td><td char="." align="char">17,305</td><td char="(" align="char">7.3 (6.2&#8211;8.7)</td><td char="(" align="char">1.3 (0.9&#8211;1.7)</td></tr><tr><td align="left">Total</td><td char="." align="char">312</td><td char="." align="char">18,764</td><td char="(" align="char">16.6 (14.9&#8211;18.6)</td><td char="(" align="char"/><td char="." align="char">440</td><td char="." align="char">62,639</td><td char="(" align="char">7.0 (6.4&#8211;7.7)</td><td char="(" align="char"/></tr><tr><td align="left" colspan="9"><italic>Overweight</italic></td></tr><tr><td align="left">APOE*2 carriers</td><td char="." align="char">59</td><td char="." align="char">3,305</td><td char="(" align="char">17.9 (13.8&#8211;23.0)</td><td char="(" align="char">1.1 (0.9&#8211;1.5)</td><td char="." align="char">65</td><td char="." align="char">11,064</td><td char="(" align="char">5.9 (4.6&#8211;7.5)</td><td char="(" align="char">0.9 (0.7&#8211;1.1)</td></tr><tr><td align="left">APOE 3/3</td><td char="." align="char">217</td><td char="." align="char">13,573</td><td char="(" align="char">16.0 (14.0&#8211;18.3)</td><td align="left"/><td char="." align="char">310</td><td char="." align="char">45,366</td><td char="(" align="char">6.8 (6.1&#8211;7.6)</td><td char="(" align="char"/></tr><tr><td align="left">APOE*4 carriers</td><td char="." align="char">90</td><td char="." align="char">6,047</td><td char="(" align="char">14.9 (12.1&#8211;18.3)</td><td char="(" align="char">0.9 (0.7&#8211;1.2)</td><td char="." align="char">137</td><td char="." align="char">19,398</td><td char="(" align="char">7.1 (6.0&#8211;8.4)</td><td char="(" align="char">1.2 (1.0&#8211;1.5)</td></tr><tr><td align="left">Total</td><td char="." align="char">366</td><td char="." align="char">22,924</td><td char="(" align="char">16.0 (14.4&#8211;17.7)</td><td char="(" align="char"/><td char="." align="char">512</td><td char="." align="char">75,827</td><td char="(" align="char">6.8 (6.2&#8211;7.4)</td><td char="(" align="char"/></tr><tr><td align="left" colspan="9"><italic>Obese</italic></td></tr><tr><td align="left">APOE*2 carriers</td><td char="." align="char">14</td><td char="." align="char">1,107</td><td char="(" align="char">12.6 (7.5&#8211;21.4)</td><td char="(" align="char">1.0 (0.5&#8211;1.8)</td><td char="." align="char">34</td><td char="." align="char">3,411</td><td char="(" align="char">10.0 (7.1&#8211;14.0)</td><td char="(" align="char">1.0 (0.6&#8211;1.5)</td></tr><tr><td align="left">APOE 3/3</td><td char="." align="char">58</td><td char="." align="char">3,816</td><td char="(" align="char">15.2 (11.7&#8211;19.7)</td><td char="(" align="char"/><td char="." align="char">113</td><td char="." align="char">12,398</td><td char="(" align="char">9.1 (7.6&#8211;11.0)</td><td char="(" align="char"/></tr><tr><td align="left">APOE*4 carriers</td><td char="." align="char">30</td><td char="." align="char">1,566</td><td char="(" align="char">19.2 (13.4&#8211;27.4)</td><td char="(" align="char">1.3 (0.9&#8211;2.0)</td><td char="." align="char">39</td><td char="." align="char">4,934</td><td char="(" align="char">7.9 (5.8&#8211;10.8)</td><td char="(" align="char">1.1 (0.8&#8211;1.6)</td></tr><tr><td align="left">Total</td><td char="." align="char">102</td><td char="." align="char">6,489</td><td char="(" align="char">15.7 (12.9&#8211;19.1)</td><td char="(" align="char"/><td char="." align="char">186</td><td char="." align="char">20,742</td><td char="(" align="char">9.0 (7.8&#8211;10.4)</td><td char="(" align="char"/></tr></tbody>
###xml 1236 2580 1236 2580 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="3"/><th align="left" colspan="2">Follow-up</th><th align="left">Incidence rate</th><th align="left">Hazard ratio</th><th align="left" colspan="2">Follow-up</th><th align="left">Incidence rate</th><th align="left">Hazard ratio</th></tr><tr><th align="left">Deaths</th><th align="left">(py)</th><th align="left">Deaths/1,000 py (95% CI)</th><th align="left">(95% CI)</th><th align="left">Deaths</th><th align="left">(py)</th><th align="left">Deaths/1,000 py (95% CI)</th><th align="left">(95% CI)</th></tr><tr><th align="left" colspan="4">Before 80&#160;years of age</th><th align="left" colspan="4">After 80&#160;years of age</th></tr></thead><tbody><tr><td align="left" colspan="9"><italic>All</italic></td></tr><tr><td align="left">APOE*2 carriers</td><td char="." align="char">101</td><td char="." align="char">6,782</td><td char="(" align="char">14.9 (12.3&#8211;18.1)</td><td char="(" align="char">0.9 (0.7&#8211;1.1)</td><td char="." align="char">156</td><td char="." align="char">21,764</td><td char="(" align="char">7.2 (6.1&#8211;8.4)</td><td char="(" align="char">0.9 (0.8&#8211;1.1)</td></tr><tr><td align="left">APOE 3/3</td><td char="." align="char">481</td><td char="." align="char">28,703</td><td char="(" align="char">16.8 (15.3&#8211;18.3)</td><td char="(" align="char"/><td char="." align="char">679</td><td char="." align="char">95,808</td><td char="(" align="char">7.1 (6.6&#8211;7.6)</td><td char="(" align="char"/></tr><tr><td align="left">APOE*4 carriers</td><td char="." align="char">198</td><td char="." align="char">12,693</td><td char="(" align="char">15.6 (13.6&#8211;17.9)</td><td char="(" align="char">1.0 (0.8&#8211;1.2)</td><td char="." align="char">303</td><td char="." align="char">41,637</td><td char="(" align="char">7.3 (6.5&#8211;8.1)</td><td char="(" align="char">1.2 (1.0&#8211;1.4)</td></tr><tr><td align="left">Total</td><td char="." align="char">780</td><td char="." align="char">48,178</td><td char="(" align="char">16.2 (15.1&#8211;17.4)</td><td char="(" align="char"/><td char="." align="char">1,138</td><td char="." align="char">159,209</td><td char="(" align="char">7.1 (6.7&#8211;7.6)</td><td char="(" align="char"/></tr><tr><td align="left" colspan="9"><italic>Normal weight</italic></td></tr><tr><td align="left">APOE*2 carriers</td><td char="." align="char">28</td><td char="." align="char">2,370</td><td char="(" align="char">11.8 (8.2&#8211;17.1)</td><td char="(" align="char">0.7 (0.5&#8211;0.9)</td><td char="." align="char">57</td><td char="." align="char">7,289</td><td char="(" align="char">7.8 (6.0&#8211;10.1)</td><td char="(" align="char">1.0 (0.8&#8211;1.4)</td></tr><tr><td align="left">APOE 3/3</td><td char="." align="char">206</td><td char="." align="char">11,314</td><td char="(" align="char">18.2 (15.9&#8211;20.9)</td><td char="(" align="char"/><td char="." align="char">256</td><td char="." align="char">38,045</td><td char="(" align="char">6.7 (6.0&#8211;7.6)</td><td char="(" align="char"/></tr><tr><td align="left">APOE*4 carriers</td><td char="." align="char">78</td><td char="." align="char">5,080</td><td char="(" align="char">15.4 (12.3&#8211;19.2)</td><td char="(" align="char">1.0 (0.7&#8211;1.3)</td><td char="." align="char">127</td><td char="." align="char">17,305</td><td char="(" align="char">7.3 (6.2&#8211;8.7)</td><td char="(" align="char">1.3 (0.9&#8211;1.7)</td></tr><tr><td align="left">Total</td><td char="." align="char">312</td><td char="." align="char">18,764</td><td char="(" align="char">16.6 (14.9&#8211;18.6)</td><td char="(" align="char"/><td char="." align="char">440</td><td char="." align="char">62,639</td><td char="(" align="char">7.0 (6.4&#8211;7.7)</td><td char="(" align="char"/></tr><tr><td align="left" colspan="9"><italic>Overweight</italic></td></tr><tr><td align="left">APOE*2 carriers</td><td char="." align="char">59</td><td char="." align="char">3,305</td><td char="(" align="char">17.9 (13.8&#8211;23.0)</td><td char="(" align="char">1.1 (0.9&#8211;1.5)</td><td char="." align="char">65</td><td char="." align="char">11,064</td><td char="(" align="char">5.9 (4.6&#8211;7.5)</td><td char="(" align="char">0.9 (0.7&#8211;1.1)</td></tr><tr><td align="left">APOE 3/3</td><td char="." align="char">217</td><td char="." align="char">13,573</td><td char="(" align="char">16.0 (14.0&#8211;18.3)</td><td align="left"/><td char="." align="char">310</td><td char="." align="char">45,366</td><td char="(" align="char">6.8 (6.1&#8211;7.6)</td><td char="(" align="char"/></tr><tr><td align="left">APOE*4 carriers</td><td char="." align="char">90</td><td char="." align="char">6,047</td><td char="(" align="char">14.9 (12.1&#8211;18.3)</td><td char="(" align="char">0.9 (0.7&#8211;1.2)</td><td char="." align="char">137</td><td char="." align="char">19,398</td><td char="(" align="char">7.1 (6.0&#8211;8.4)</td><td char="(" align="char">1.2 (1.0&#8211;1.5)</td></tr><tr><td align="left">Total</td><td char="." align="char">366</td><td char="." align="char">22,924</td><td char="(" align="char">16.0 (14.4&#8211;17.7)</td><td char="(" align="char"/><td char="." align="char">512</td><td char="." align="char">75,827</td><td char="(" align="char">6.8 (6.2&#8211;7.4)</td><td char="(" align="char"/></tr><tr><td align="left" colspan="9"><italic>Obese</italic></td></tr><tr><td align="left">APOE*2 carriers</td><td char="." align="char">14</td><td char="." align="char">1,107</td><td char="(" align="char">12.6 (7.5&#8211;21.4)</td><td char="(" align="char">1.0 (0.5&#8211;1.8)</td><td char="." align="char">34</td><td char="." align="char">3,411</td><td char="(" align="char">10.0 (7.1&#8211;14.0)</td><td char="(" align="char">1.0 (0.6&#8211;1.5)</td></tr><tr><td align="left">APOE 3/3</td><td char="." align="char">58</td><td char="." align="char">3,816</td><td char="(" align="char">15.2 (11.7&#8211;19.7)</td><td char="(" align="char"/><td char="." align="char">113</td><td char="." align="char">12,398</td><td char="(" align="char">9.1 (7.6&#8211;11.0)</td><td char="(" align="char"/></tr><tr><td align="left">APOE*4 carriers</td><td char="." align="char">30</td><td char="." align="char">1,566</td><td char="(" align="char">19.2 (13.4&#8211;27.4)</td><td char="(" align="char">1.3 (0.9&#8211;2.0)</td><td char="." align="char">39</td><td char="." align="char">4,934</td><td char="(" align="char">7.9 (5.8&#8211;10.8)</td><td char="(" align="char">1.1 (0.8&#8211;1.6)</td></tr><tr><td align="left">Total</td><td char="." align="char">102</td><td char="." align="char">6,489</td><td char="(" align="char">15.7 (12.9&#8211;19.1)</td><td char="(" align="char"/><td char="." align="char">186</td><td char="." align="char">20,742</td><td char="(" align="char">9.0 (7.8&#8211;10.4)</td><td char="(" align="char"/></tr></tbody></table>
###xml 2580 2764 2580 2764 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="27">Hazard ratios adjusted for sex, waist-hip-ratio, smoking, education level, total serum cholesterol, HDL cholesterol hypertension and diabetes; py: person-years; CI: Confidence interval</p>
###xml 2580 2764 2580 2764 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="27">Hazard ratios adjusted for sex, waist-hip-ratio, smoking, education level, total serum cholesterol, HDL cholesterol hypertension and diabetes; py: person-years; CI: Confidence interval</p></table-wrap-foot>
###xml 1135 2764 1135 2764 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab2"><label>Table&#160;2</label><caption><p textid="26">Incidence rates and hazard ratios for all-cause mortality by <italic>APOE</italic> genotypes and BMI categories</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="3"/><th align="left" colspan="2">Follow-up</th><th align="left">Incidence rate</th><th align="left">Hazard ratio</th><th align="left" colspan="2">Follow-up</th><th align="left">Incidence rate</th><th align="left">Hazard ratio</th></tr><tr><th align="left">Deaths</th><th align="left">(py)</th><th align="left">Deaths/1,000 py (95% CI)</th><th align="left">(95% CI)</th><th align="left">Deaths</th><th align="left">(py)</th><th align="left">Deaths/1,000 py (95% CI)</th><th align="left">(95% CI)</th></tr><tr><th align="left" colspan="4">Before 80&#160;years of age</th><th align="left" colspan="4">After 80&#160;years of age</th></tr></thead><tbody><tr><td align="left" colspan="9"><italic>All</italic></td></tr><tr><td align="left">APOE*2 carriers</td><td char="." align="char">101</td><td char="." align="char">6,782</td><td char="(" align="char">14.9 (12.3&#8211;18.1)</td><td char="(" align="char">0.9 (0.7&#8211;1.1)</td><td char="." align="char">156</td><td char="." align="char">21,764</td><td char="(" align="char">7.2 (6.1&#8211;8.4)</td><td char="(" align="char">0.9 (0.8&#8211;1.1)</td></tr><tr><td align="left">APOE 3/3</td><td char="." align="char">481</td><td char="." align="char">28,703</td><td char="(" align="char">16.8 (15.3&#8211;18.3)</td><td char="(" align="char"/><td char="." align="char">679</td><td char="." align="char">95,808</td><td char="(" align="char">7.1 (6.6&#8211;7.6)</td><td char="(" align="char"/></tr><tr><td align="left">APOE*4 carriers</td><td char="." align="char">198</td><td char="." align="char">12,693</td><td char="(" align="char">15.6 (13.6&#8211;17.9)</td><td char="(" align="char">1.0 (0.8&#8211;1.2)</td><td char="." align="char">303</td><td char="." align="char">41,637</td><td char="(" align="char">7.3 (6.5&#8211;8.1)</td><td char="(" align="char">1.2 (1.0&#8211;1.4)</td></tr><tr><td align="left">Total</td><td char="." align="char">780</td><td char="." align="char">48,178</td><td char="(" align="char">16.2 (15.1&#8211;17.4)</td><td char="(" align="char"/><td char="." align="char">1,138</td><td char="." align="char">159,209</td><td char="(" align="char">7.1 (6.7&#8211;7.6)</td><td char="(" align="char"/></tr><tr><td align="left" colspan="9"><italic>Normal weight</italic></td></tr><tr><td align="left">APOE*2 carriers</td><td char="." align="char">28</td><td char="." align="char">2,370</td><td char="(" align="char">11.8 (8.2&#8211;17.1)</td><td char="(" align="char">0.7 (0.5&#8211;0.9)</td><td char="." align="char">57</td><td char="." align="char">7,289</td><td char="(" align="char">7.8 (6.0&#8211;10.1)</td><td char="(" align="char">1.0 (0.8&#8211;1.4)</td></tr><tr><td align="left">APOE 3/3</td><td char="." align="char">206</td><td char="." align="char">11,314</td><td char="(" align="char">18.2 (15.9&#8211;20.9)</td><td char="(" align="char"/><td char="." align="char">256</td><td char="." align="char">38,045</td><td char="(" align="char">6.7 (6.0&#8211;7.6)</td><td char="(" align="char"/></tr><tr><td align="left">APOE*4 carriers</td><td char="." align="char">78</td><td char="." align="char">5,080</td><td char="(" align="char">15.4 (12.3&#8211;19.2)</td><td char="(" align="char">1.0 (0.7&#8211;1.3)</td><td char="." align="char">127</td><td char="." align="char">17,305</td><td char="(" align="char">7.3 (6.2&#8211;8.7)</td><td char="(" align="char">1.3 (0.9&#8211;1.7)</td></tr><tr><td align="left">Total</td><td char="." align="char">312</td><td char="." align="char">18,764</td><td char="(" align="char">16.6 (14.9&#8211;18.6)</td><td char="(" align="char"/><td char="." align="char">440</td><td char="." align="char">62,639</td><td char="(" align="char">7.0 (6.4&#8211;7.7)</td><td char="(" align="char"/></tr><tr><td align="left" colspan="9"><italic>Overweight</italic></td></tr><tr><td align="left">APOE*2 carriers</td><td char="." align="char">59</td><td char="." align="char">3,305</td><td char="(" align="char">17.9 (13.8&#8211;23.0)</td><td char="(" align="char">1.1 (0.9&#8211;1.5)</td><td char="." align="char">65</td><td char="." align="char">11,064</td><td char="(" align="char">5.9 (4.6&#8211;7.5)</td><td char="(" align="char">0.9 (0.7&#8211;1.1)</td></tr><tr><td align="left">APOE 3/3</td><td char="." align="char">217</td><td char="." align="char">13,573</td><td char="(" align="char">16.0 (14.0&#8211;18.3)</td><td align="left"/><td char="." align="char">310</td><td char="." align="char">45,366</td><td char="(" align="char">6.8 (6.1&#8211;7.6)</td><td char="(" align="char"/></tr><tr><td align="left">APOE*4 carriers</td><td char="." align="char">90</td><td char="." align="char">6,047</td><td char="(" align="char">14.9 (12.1&#8211;18.3)</td><td char="(" align="char">0.9 (0.7&#8211;1.2)</td><td char="." align="char">137</td><td char="." align="char">19,398</td><td char="(" align="char">7.1 (6.0&#8211;8.4)</td><td char="(" align="char">1.2 (1.0&#8211;1.5)</td></tr><tr><td align="left">Total</td><td char="." align="char">366</td><td char="." align="char">22,924</td><td char="(" align="char">16.0 (14.4&#8211;17.7)</td><td char="(" align="char"/><td char="." align="char">512</td><td char="." align="char">75,827</td><td char="(" align="char">6.8 (6.2&#8211;7.4)</td><td char="(" align="char"/></tr><tr><td align="left" colspan="9"><italic>Obese</italic></td></tr><tr><td align="left">APOE*2 carriers</td><td char="." align="char">14</td><td char="." align="char">1,107</td><td char="(" align="char">12.6 (7.5&#8211;21.4)</td><td char="(" align="char">1.0 (0.5&#8211;1.8)</td><td char="." align="char">34</td><td char="." align="char">3,411</td><td char="(" align="char">10.0 (7.1&#8211;14.0)</td><td char="(" align="char">1.0 (0.6&#8211;1.5)</td></tr><tr><td align="left">APOE 3/3</td><td char="." align="char">58</td><td char="." align="char">3,816</td><td char="(" align="char">15.2 (11.7&#8211;19.7)</td><td char="(" align="char"/><td char="." align="char">113</td><td char="." align="char">12,398</td><td char="(" align="char">9.1 (7.6&#8211;11.0)</td><td char="(" align="char"/></tr><tr><td align="left">APOE*4 carriers</td><td char="." align="char">30</td><td char="." align="char">1,566</td><td char="(" align="char">19.2 (13.4&#8211;27.4)</td><td char="(" align="char">1.3 (0.9&#8211;2.0)</td><td char="." align="char">39</td><td char="." align="char">4,934</td><td char="(" align="char">7.9 (5.8&#8211;10.8)</td><td char="(" align="char">1.1 (0.8&#8211;1.6)</td></tr><tr><td align="left">Total</td><td char="." align="char">102</td><td char="." align="char">6,489</td><td char="(" align="char">15.7 (12.9&#8211;19.1)</td><td char="(" align="char"/><td char="." align="char">186</td><td char="." align="char">20,742</td><td char="(" align="char">9.0 (7.8&#8211;10.4)</td><td char="(" align="char"/></tr></tbody></table><table-wrap-foot><p textid="27">Hazard ratios adjusted for sex, waist-hip-ratio, smoking, education level, total serum cholesterol, HDL cholesterol hypertension and diabetes; py: person-years; CI: Confidence interval</p></table-wrap-foot></table-wrap>
###xml 2764 2770 2764 2770 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;3</label>
###xml 2826 2830 2826 2830 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 2770 2892 2770 2892 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="28">Kaplan Meier survival curves for all-cause mortality by <italic>APOE</italic> genotypes for normal weight, overweight and obese individuals</p>
###xml 2770 2892 2770 2892 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="28">Kaplan Meier survival curves for all-cause mortality by <italic>APOE</italic> genotypes for normal weight, overweight and obese individuals</p></caption>
###xml 2892 2892 2892 2892 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="10654_2007_9202_Fig3_HTML" id="MO3"/>
###xml 2764 2892 2764 2892 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig3"><label>Fig.&#160;3</label><caption><p textid="28">Kaplan Meier survival curves for all-cause mortality by <italic>APOE</italic> genotypes for normal weight, overweight and obese individuals</p></caption><graphic position="anchor" xlink:href="10654_2007_9202_Fig3_HTML" id="MO3"/></fig>
###xml 1040 1047 <span type="species:ncbi:9606">persons</span>
###xml 2727 2733 <span type="species:ncbi:9606">person</span>
A total of 1,918 deaths occurred during follow-up. Of those, 257 occurred in 782 APOE*2 carriers (33%), 1,160 in 3,369 APOE*3 homozygotes (33%) and 501 in 1,457 APOE*4 carriers (34%). Differences between the Kaplan-Meier survival curves of the APOE*2 carriers, APOE*3 homozygotes and APOE*4 carriers were small but statistically significant (p = 0.03) with APOE*2 carriers having slightly lower mortality risks (Fig. 2). After adjustment for other cardiovascular risk factors, APOE genotype was not associated with all-cause mortality before or after 80 years of age in the overall population (Table 2). The differences between the curves were only statistically significant in normal weight individuals (p = 0.04; Fig. 3). Normal weight carriers of the APOE*2 allele had a significantly lower risk of mortality before age 80 years (HR [95% CI] = 0.7 [0.5-0.9]), but not after age 80 years (crude HR [95% CI] = 1.0 [0.8-1.4]). There were no significant differences in the risk of mortality between genotype groups among overweight or obese persons (Table 2). Fig. 2Kaplan Meier survival curves for all-cause mortality by APOE genotypesTable 2Incidence rates and hazard ratios for all-cause mortality by APOE genotypes and BMI categoriesFollow-upIncidence rateHazard ratioFollow-upIncidence rateHazard ratioDeaths(py)Deaths/1,000 py (95% CI)(95% CI)Deaths(py)Deaths/1,000 py (95% CI)(95% CI)Before 80 years of ageAfter 80 years of ageAllAPOE*2 carriers1016,78214.9 (12.3-18.1)0.9 (0.7-1.1)15621,7647.2 (6.1-8.4)0.9 (0.8-1.1)APOE 3/348128,70316.8 (15.3-18.3)67995,8087.1 (6.6-7.6)APOE*4 carriers19812,69315.6 (13.6-17.9)1.0 (0.8-1.2)30341,6377.3 (6.5-8.1)1.2 (1.0-1.4)Total78048,17816.2 (15.1-17.4)1,138159,2097.1 (6.7-7.6)Normal weightAPOE*2 carriers282,37011.8 (8.2-17.1)0.7 (0.5-0.9)577,2897.8 (6.0-10.1)1.0 (0.8-1.4)APOE 3/320611,31418.2 (15.9-20.9)25638,0456.7 (6.0-7.6)APOE*4 carriers785,08015.4 (12.3-19.2)1.0 (0.7-1.3)12717,3057.3 (6.2-8.7)1.3 (0.9-1.7)Total31218,76416.6 (14.9-18.6)44062,6397.0 (6.4-7.7)OverweightAPOE*2 carriers593,30517.9 (13.8-23.0)1.1 (0.9-1.5)6511,0645.9 (4.6-7.5)0.9 (0.7-1.1)APOE 3/321713,57316.0 (14.0-18.3)31045,3666.8 (6.1-7.6)APOE*4 carriers906,04714.9 (12.1-18.3)0.9 (0.7-1.2)13719,3987.1 (6.0-8.4)1.2 (1.0-1.5)Total36622,92416.0 (14.4-17.7)51275,8276.8 (6.2-7.4)ObeseAPOE*2 carriers141,10712.6 (7.5-21.4)1.0 (0.5-1.8)343,41110.0 (7.1-14.0)1.0 (0.6-1.5)APOE 3/3583,81615.2 (11.7-19.7)11312,3989.1 (7.6-11.0)APOE*4 carriers301,56619.2 (13.4-27.4)1.3 (0.9-2.0)394,9347.9 (5.8-10.8)1.1 (0.8-1.6)Total1026,48915.7 (12.9-19.1)18620,7429.0 (7.8-10.4)Hazard ratios adjusted for sex, waist-hip-ratio, smoking, education level, total serum cholesterol, HDL cholesterol hypertension and diabetes; py: person-years; CI: Confidence intervalFig. 3Kaplan Meier survival curves for all-cause mortality by APOE genotypes for normal weight, overweight and obese individuals
###end p 24
###begin p 25
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
Kaplan Meier survival curves for all-cause mortality by APOE genotypes
###end p 25
###begin p 26
###xml 61 65 61 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
Incidence rates and hazard ratios for all-cause mortality by APOE genotypes and BMI categories
###end p 26
###begin p 27
###xml 147 153 <span type="species:ncbi:9606">person</span>
Hazard ratios adjusted for sex, waist-hip-ratio, smoking, education level, total serum cholesterol, HDL cholesterol hypertension and diabetes; py: person-years; CI: Confidence interval
###end p 27
###begin p 28
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
Kaplan Meier survival curves for all-cause mortality by APOE genotypes for normal weight, overweight and obese individuals
###end p 28
###begin p 29
###xml 80 85 80 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 195 199 195 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 315 319 315 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 537 538 537 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab3" ref-type="table">3</xref>
###xml 541 548 541 548 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;3</label>
###xml 603 607 603 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 548 636 548 636 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="30">Incidence rates and hazard ratios for CHD mortality by <italic>APOE</italic> genotypes and BMI categories</p>
###xml 548 636 548 636 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="30">Incidence rates and hazard ratios for CHD mortality by <italic>APOE</italic> genotypes and BMI categories</p></caption>
###xml 636 636 636 636 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="3"/>
###xml 636 645 636 645 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="2">Follow-up</th>
###xml 645 659 645 659 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Incidence rate</th>
###xml 659 671 659 671 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Hazard ratio</th>
###xml 671 680 671 680 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="2">Follow-up</th>
###xml 680 694 680 694 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Incidence rate</th>
###xml 694 706 694 706 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Hazard ratio</th>
###xml 636 706 636 706 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left" rowspan="3"/><th align="left" colspan="2">Follow-up</th><th align="left">Incidence rate</th><th align="left">Hazard ratio</th><th align="left" colspan="2">Follow-up</th><th align="left">Incidence rate</th><th align="left">Hazard ratio</th></tr>
###xml 706 712 706 712 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Deaths</th>
###xml 712 716 712 716 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">(py)</th>
###xml 716 740 716 740 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Deaths/1,000 py (95% CI)</th>
###xml 740 748 740 748 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">(95% CI)</th>
###xml 748 754 748 754 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Deaths</th>
###xml 754 758 754 758 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">(py)</th>
###xml 758 782 758 782 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Deaths/1,000 py (95% CI)</th>
###xml 782 790 782 790 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">(95% CI)</th>
###xml 706 790 706 790 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Deaths</th><th align="left">(py)</th><th align="left">Deaths/1,000 py (95% CI)</th><th align="left">(95% CI)</th><th align="left">Deaths</th><th align="left">(py)</th><th align="left">Deaths/1,000 py (95% CI)</th><th align="left">(95% CI)</th></tr>
###xml 790 812 790 812 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="4">Before 80&#160;years of age</th>
###xml 812 833 812 833 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="4">After 80&#160;years of age</th>
###xml 790 833 790 833 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left" colspan="4">Before 80&#160;years of age</th><th align="left" colspan="4">After 80&#160;years of age</th></tr>
###xml 636 833 636 833 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left" rowspan="3"/><th align="left" colspan="2">Follow-up</th><th align="left">Incidence rate</th><th align="left">Hazard ratio</th><th align="left" colspan="2">Follow-up</th><th align="left">Incidence rate</th><th align="left">Hazard ratio</th></tr><tr><th align="left">Deaths</th><th align="left">(py)</th><th align="left">Deaths/1,000 py (95% CI)</th><th align="left">(95% CI)</th><th align="left">Deaths</th><th align="left">(py)</th><th align="left">Deaths/1,000 py (95% CI)</th><th align="left">(95% CI)</th></tr><tr><th align="left" colspan="4">Before 80&#160;years of age</th><th align="left" colspan="4">After 80&#160;years of age</th></tr></thead>
###xml 833 836 833 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink">All</italic>
###xml 833 836 833 836 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="9"><italic>All</italic></td>
###xml 833 836 833 836 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="9"><italic>All</italic></td></tr>
###xml 836 851 836 851 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">APOE*2 carriers</td>
###xml 851 853 851 853 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">26</td>
###xml 853 858 853 858 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">6,782</td>
###xml 858 871 858 871 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">3.8 (2.6&#8211;5.6)</td>
###xml 871 884 871 884 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1.0 (0.6&#8211;1.5)</td>
###xml 884 886 884 886 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">41</td>
###xml 886 891 886 891 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2,103</td>
###xml 891 907 891 907 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">19.5 (14.4&#8211;26.5)</td>
###xml 907 920 907 920 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1.1 (0.8&#8211;1.5)</td>
###xml 836 920 836 920 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">APOE*2 carriers</td><td char="." align="char">26</td><td char="." align="char">6,782</td><td char="(" align="char">3.8 (2.6&#8211;5.6)</td><td char="(" align="char">1.0 (0.6&#8211;1.5)</td><td char="." align="char">41</td><td char="." align="char">2,103</td><td char="(" align="char">19.5 (14.4&#8211;26.5)</td><td char="(" align="char">1.1 (0.8&#8211;1.5)</td></tr>
###xml 920 928 920 928 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">APOE 3/3</td>
###xml 928 931 928 931 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">126</td>
###xml 931 937 931 937 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">28,703</td>
###xml 937 950 937 950 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">4.4 (3.7&#8211;5.2)</td>
###xml 950 950 950 950 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 950 953 950 953 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">171</td>
###xml 953 958 953 958 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">8,744</td>
###xml 958 974 958 974 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">19.6 (16.8&#8211;22.7)</td>
###xml 974 974 974 974 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 920 974 920 974 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">APOE 3/3</td><td char="." align="char">126</td><td char="." align="char">28,703</td><td char="(" align="char">4.4 (3.7&#8211;5.2)</td><td char="(" align="char"/><td char="." align="char">171</td><td char="." align="char">8,744</td><td char="(" align="char">19.6 (16.8&#8211;22.7)</td><td char="(" align="char"/></tr>
###xml 974 989 974 989 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">APOE*4 carriers</td>
###xml 989 991 989 991 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">59</td>
###xml 991 997 991 997 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">12,693</td>
###xml 997 1010 997 1010 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">4.6 (3.6&#8211;6.0)</td>
###xml 1010 1023 1010 1023 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1.1 (0.8&#8211;1.4)</td>
###xml 1023 1025 1023 1025 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">66</td>
###xml 1025 1030 1025 1030 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3,472</td>
###xml 1030 1046 1030 1046 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">19.0 (14.9&#8211;24.2)</td>
###xml 1046 1059 1046 1059 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1.1 (0.8&#8211;1.4)</td>
###xml 974 1059 974 1059 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">APOE*4 carriers</td><td char="." align="char">59</td><td char="." align="char">12,693</td><td char="(" align="char">4.6 (3.6&#8211;6.0)</td><td char="(" align="char">1.1 (0.8&#8211;1.4)</td><td char="." align="char">66</td><td char="." align="char">3,472</td><td char="(" align="char">19.0 (14.9&#8211;24.2)</td><td char="(" align="char">1.1 (0.8&#8211;1.4)</td></tr>
###xml 1059 1064 1059 1064 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Total</td>
###xml 1064 1067 1064 1067 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">211</td>
###xml 1067 1073 1067 1073 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">48,178</td>
###xml 1073 1086 1073 1086 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">4.4 (3.8&#8211;5.0)</td>
###xml 1086 1086 1086 1086 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 1086 1089 1086 1089 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">278</td>
###xml 1089 1095 1089 1095 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">14,319</td>
###xml 1095 1111 1095 1111 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">19.4 (17.3&#8211;21.8)</td>
###xml 1111 1111 1111 1111 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 1059 1111 1059 1111 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Total</td><td char="." align="char">211</td><td char="." align="char">48,178</td><td char="(" align="char">4.4 (3.8&#8211;5.0)</td><td char="(" align="char"/><td char="." align="char">278</td><td char="." align="char">14,319</td><td char="(" align="char">19.4 (17.3&#8211;21.8)</td><td char="(" align="char"/></tr>
###xml 1111 1124 1111 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Normal weight</italic>
###xml 1111 1124 1111 1124 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="9"><italic>Normal weight</italic></td>
###xml 1111 1124 1111 1124 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="9"><italic>Normal weight</italic></td></tr>
###xml 1124 1139 1124 1139 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">APOE*2 carriers</td>
###xml 1139 1140 1139 1140 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">5</td>
###xml 1140 1145 1140 1145 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2,370</td>
###xml 1145 1158 1145 1158 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">2.1 (0.9&#8211;5.1)</td>
###xml 1158 1171 1158 1171 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0.5 (0.2&#8211;1.2)</td>
###xml 1171 1173 1171 1173 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">15</td>
###xml 1173 1176 1173 1176 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">663</td>
###xml 1176 1192 1176 1192 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">22.6 (13.6&#8211;37.5)</td>
###xml 1192 1205 1192 1205 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1.6 (0.9&#8211;2.9)</td>
###xml 1124 1205 1124 1205 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">APOE*2 carriers</td><td char="." align="char">5</td><td char="." align="char">2,370</td><td char="(" align="char">2.1 (0.9&#8211;5.1)</td><td char="(" align="char">0.5 (0.2&#8211;1.2)</td><td char="." align="char">15</td><td char="." align="char">663</td><td char="(" align="char">22.6 (13.6&#8211;37.5)</td><td char="(" align="char">1.6 (0.9&#8211;2.9)</td></tr>
###xml 1205 1213 1205 1213 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">APOE 3/3</td>
###xml 1213 1215 1213 1215 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">56</td>
###xml 1215 1221 1215 1221 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">11,314</td>
###xml 1221 1234 1221 1234 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">4.9 (3.8&#8211;6.4)</td>
###xml 1234 1234 1234 1234 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 1234 1236 1234 1236 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">48</td>
###xml 1236 1241 1236 1241 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3,075</td>
###xml 1241 1257 1241 1257 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">15.6 (11.8&#8211;20.7)</td>
###xml 1257 1257 1257 1257 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 1205 1257 1205 1257 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">APOE 3/3</td><td char="." align="char">56</td><td char="." align="char">11,314</td><td char="(" align="char">4.9 (3.8&#8211;6.4)</td><td char="(" align="char"/><td char="." align="char">48</td><td char="." align="char">3,075</td><td char="(" align="char">15.6 (11.8&#8211;20.7)</td><td char="(" align="char"/></tr>
###xml 1257 1272 1257 1272 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">APOE*4 carriers</td>
###xml 1272 1274 1272 1274 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">26</td>
###xml 1274 1279 1274 1279 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">5,080</td>
###xml 1279 1292 1279 1292 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5.1 (3.5&#8211;7.5)</td>
###xml 1292 1305 1292 1305 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1.2 (0.7&#8211;1.9)</td>
###xml 1305 1307 1305 1307 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">21</td>
###xml 1307 1312 1307 1312 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1,286</td>
###xml 1312 1328 1312 1328 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">16.3 (10.6&#8211;25.1)</td>
###xml 1328 1341 1328 1341 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1.1 (0.6&#8211;1.8)</td>
###xml 1257 1341 1257 1341 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">APOE*4 carriers</td><td char="." align="char">26</td><td char="." align="char">5,080</td><td char="(" align="char">5.1 (3.5&#8211;7.5)</td><td char="(" align="char">1.2 (0.7&#8211;1.9)</td><td char="." align="char">21</td><td char="." align="char">1,286</td><td char="(" align="char">16.3 (10.6&#8211;25.1)</td><td char="(" align="char">1.1 (0.6&#8211;1.8)</td></tr>
###xml 1341 1346 1341 1346 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Total</td>
###xml 1346 1348 1346 1348 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">87</td>
###xml 1348 1354 1348 1354 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">18,764</td>
###xml 1354 1367 1354 1367 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">4.6 (3.8&#8211;5.7)</td>
###xml 1367 1367 1367 1367 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 1367 1369 1367 1369 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">84</td>
###xml 1369 1374 1369 1374 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">5,024</td>
###xml 1374 1390 1374 1390 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">16.7 (13.5&#8211;20.7)</td>
###xml 1390 1390 1390 1390 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 1341 1390 1341 1390 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Total</td><td char="." align="char">87</td><td char="." align="char">18,764</td><td char="(" align="char">4.6 (3.8&#8211;5.7)</td><td char="(" align="char"/><td char="." align="char">84</td><td char="." align="char">5,024</td><td char="(" align="char">16.7 (13.5&#8211;20.7)</td><td char="(" align="char"/></tr>
###xml 1390 1400 1390 1400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Overweight</italic>
###xml 1390 1400 1390 1400 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="9"><italic>Overweight</italic></td>
###xml 1390 1400 1390 1400 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="9"><italic>Overweight</italic></td></tr>
###xml 1400 1415 1400 1415 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">APOE*2 carriers</td>
###xml 1415 1417 1415 1417 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">16</td>
###xml 1417 1422 1417 1422 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3,305</td>
###xml 1422 1435 1422 1435 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">4.8 (3.0&#8211;7.9)</td>
###xml 1435 1448 1435 1448 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1.4 (0.8&#8211;2.4)</td>
###xml 1448 1450 1448 1450 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">15</td>
###xml 1450 1453 1450 1453 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">989</td>
###xml 1453 1468 1453 1468 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">15.2 (9.1&#8211;25.2)</td>
###xml 1468 1481 1468 1481 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0.7 (0.4&#8211;1.3)</td>
###xml 1400 1481 1400 1481 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">APOE*2 carriers</td><td char="." align="char">16</td><td char="." align="char">3,305</td><td char="(" align="char">4.8 (3.0&#8211;7.9)</td><td char="(" align="char">1.4 (0.8&#8211;2.4)</td><td char="." align="char">15</td><td char="." align="char">989</td><td char="(" align="char">15.2 (9.1&#8211;25.2)</td><td char="(" align="char">0.7 (0.4&#8211;1.3)</td></tr>
###xml 1481 1489 1481 1489 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">APOE 3/3</td>
###xml 1489 1491 1489 1491 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">51</td>
###xml 1491 1497 1491 1497 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">13,573</td>
###xml 1497 1510 1497 1510 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">3.8 (2.9&#8211;4.9)</td>
###xml 1510 1510 1510 1510 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 1510 1512 1510 1512 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">92</td>
###xml 1512 1517 1512 1517 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">4,035</td>
###xml 1517 1533 1517 1533 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">22.8 (18.6&#8211;28.0)</td>
###xml 1533 1533 1533 1533 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 1481 1533 1481 1533 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">APOE 3/3</td><td char="." align="char">51</td><td char="." align="char">13,573</td><td char="(" align="char">3.8 (2.9&#8211;4.9)</td><td char="(" align="char"/><td char="." align="char">92</td><td char="." align="char">4,035</td><td char="(" align="char">22.8 (18.6&#8211;28.0)</td><td char="(" align="char"/></tr>
###xml 1533 1548 1533 1548 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">APOE*4 carriers</td>
###xml 1548 1550 1548 1550 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">21</td>
###xml 1550 1555 1550 1555 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">6,047</td>
###xml 1555 1568 1555 1568 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">3.5 (2.3&#8211;5.3)</td>
###xml 1568 1581 1568 1581 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0.8 (0.5&#8211;1.4)</td>
###xml 1581 1583 1581 1583 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">35</td>
###xml 1583 1588 1583 1588 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1,619</td>
###xml 1588 1604 1588 1604 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">21.6 (15.5&#8211;30.1)</td>
###xml 1604 1617 1604 1617 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1.0 (0.7&#8211;1.5)</td>
###xml 1533 1617 1533 1617 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">APOE*4 carriers</td><td char="." align="char">21</td><td char="." align="char">6,047</td><td char="(" align="char">3.5 (2.3&#8211;5.3)</td><td char="(" align="char">0.8 (0.5&#8211;1.4)</td><td char="." align="char">35</td><td char="." align="char">1,619</td><td char="(" align="char">21.6 (15.5&#8211;30.1)</td><td char="(" align="char">1.0 (0.7&#8211;1.5)</td></tr>
###xml 1617 1622 1617 1622 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Total</td>
###xml 1622 1624 1622 1624 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">88</td>
###xml 1624 1630 1624 1630 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">22,924</td>
###xml 1630 1643 1630 1643 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">3.8 (3.1&#8211;4.7)</td>
###xml 1643 1643 1643 1643 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 1643 1646 1643 1646 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">142</td>
###xml 1646 1651 1646 1651 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">6,643</td>
###xml 1651 1667 1651 1667 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">21.4 (18.1&#8211;25.2)</td>
###xml 1667 1667 1667 1667 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 1617 1667 1617 1667 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Total</td><td char="." align="char">88</td><td char="." align="char">22,924</td><td char="(" align="char">3.8 (3.1&#8211;4.7)</td><td char="(" align="char"/><td char="." align="char">142</td><td char="." align="char">6,643</td><td char="(" align="char">21.4 (18.1&#8211;25.2)</td><td char="(" align="char"/></tr>
###xml 1667 1672 1667 1672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Obese</italic>
###xml 1667 1672 1667 1672 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="9"><italic>Obese</italic></td>
###xml 1667 1672 1667 1672 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="9"><italic>Obese</italic></td></tr>
###xml 1672 1687 1672 1687 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">APOE*2 carriers</td>
###xml 1687 1688 1687 1688 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">5</td>
###xml 1688 1693 1688 1693 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1,107</td>
###xml 1693 1707 1693 1707 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">4.5 (1.9&#8211;10.8)</td>
###xml 1707 1720 1707 1720 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1.1 (0.4&#8211;3.4)</td>
###xml 1720 1722 1720 1722 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">11</td>
###xml 1722 1725 1722 1725 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">450</td>
###xml 1725 1741 1725 1741 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">24.4 (13.5&#8211;44.1)</td>
###xml 1741 1754 1741 1754 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1.4 (0.7&#8211;3.1)</td>
###xml 1672 1754 1672 1754 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">APOE*2 carriers</td><td char="." align="char">5</td><td char="." align="char">1,107</td><td char="(" align="char">4.5 (1.9&#8211;10.8)</td><td char="(" align="char">1.1 (0.4&#8211;3.4)</td><td char="." align="char">11</td><td char="." align="char">450</td><td char="(" align="char">24.4 (13.5&#8211;44.1)</td><td char="(" align="char">1.4 (0.7&#8211;3.1)</td></tr>
###xml 1754 1762 1754 1762 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">APOE 3/3</td>
###xml 1762 1764 1762 1764 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">19</td>
###xml 1764 1769 1764 1769 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">3,816</td>
###xml 1769 1782 1769 1782 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5.0 (3.2&#8211;7.8)</td>
###xml 1782 1782 1782 1782 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 1782 1784 1782 1784 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">31</td>
###xml 1784 1789 1784 1789 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1,634</td>
###xml 1789 1805 1789 1805 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">19.0 (13.3&#8211;27.0)</td>
###xml 1805 1805 1805 1805 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 1754 1805 1754 1805 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">APOE 3/3</td><td char="." align="char">19</td><td char="." align="char">3,816</td><td char="(" align="char">5.0 (3.2&#8211;7.8)</td><td char="(" align="char"/><td char="." align="char">31</td><td char="." align="char">1,634</td><td char="(" align="char">19.0 (13.3&#8211;27.0)</td><td char="(" align="char"/></tr>
###xml 1805 1820 1805 1820 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">APOE*4 carriers</td>
###xml 1820 1822 1820 1822 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">12</td>
###xml 1822 1827 1822 1827 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">1,566</td>
###xml 1827 1841 1827 1841 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">7.7 (4.4&#8211;13.5)</td>
###xml 1841 1854 1841 1854 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1.6 (0.8&#8211;3.5)</td>
###xml 1854 1856 1854 1856 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">10</td>
###xml 1856 1859 1856 1859 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">568</td>
###xml 1859 1874 1859 1874 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">17.6 (9.5&#8211;32.7)</td>
###xml 1874 1887 1874 1887 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1.1 (0.5&#8211;2.2)</td>
###xml 1805 1887 1805 1887 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">APOE*4 carriers</td><td char="." align="char">12</td><td char="." align="char">1,566</td><td char="(" align="char">7.7 (4.4&#8211;13.5)</td><td char="(" align="char">1.6 (0.8&#8211;3.5)</td><td char="." align="char">10</td><td char="." align="char">568</td><td char="(" align="char">17.6 (9.5&#8211;32.7)</td><td char="(" align="char">1.1 (0.5&#8211;2.2)</td></tr>
###xml 1887 1892 1887 1892 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Total</td>
###xml 1892 1894 1892 1894 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">36</td>
###xml 1894 1899 1894 1899 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">6,489</td>
###xml 1899 1912 1899 1912 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5.5 (4.0&#8211;7.7)</td>
###xml 1912 1912 1912 1912 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 1912 1914 1912 1914 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">52</td>
###xml 1914 1919 1914 1919 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">2,651</td>
###xml 1919 1935 1919 1935 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">19.6 (14.9&#8211;25.7)</td>
###xml 1935 1935 1935 1935 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 1887 1935 1887 1935 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Total</td><td char="." align="char">36</td><td char="." align="char">6,489</td><td char="(" align="char">5.5 (4.0&#8211;7.7)</td><td char="(" align="char"/><td char="." align="char">52</td><td char="." align="char">2,651</td><td char="(" align="char">19.6 (14.9&#8211;25.7)</td><td char="(" align="char"/></tr>
###xml 833 1935 833 1935 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left" colspan="9"><italic>All</italic></td></tr><tr><td align="left">APOE*2 carriers</td><td char="." align="char">26</td><td char="." align="char">6,782</td><td char="(" align="char">3.8 (2.6&#8211;5.6)</td><td char="(" align="char">1.0 (0.6&#8211;1.5)</td><td char="." align="char">41</td><td char="." align="char">2,103</td><td char="(" align="char">19.5 (14.4&#8211;26.5)</td><td char="(" align="char">1.1 (0.8&#8211;1.5)</td></tr><tr><td align="left">APOE 3/3</td><td char="." align="char">126</td><td char="." align="char">28,703</td><td char="(" align="char">4.4 (3.7&#8211;5.2)</td><td char="(" align="char"/><td char="." align="char">171</td><td char="." align="char">8,744</td><td char="(" align="char">19.6 (16.8&#8211;22.7)</td><td char="(" align="char"/></tr><tr><td align="left">APOE*4 carriers</td><td char="." align="char">59</td><td char="." align="char">12,693</td><td char="(" align="char">4.6 (3.6&#8211;6.0)</td><td char="(" align="char">1.1 (0.8&#8211;1.4)</td><td char="." align="char">66</td><td char="." align="char">3,472</td><td char="(" align="char">19.0 (14.9&#8211;24.2)</td><td char="(" align="char">1.1 (0.8&#8211;1.4)</td></tr><tr><td align="left">Total</td><td char="." align="char">211</td><td char="." align="char">48,178</td><td char="(" align="char">4.4 (3.8&#8211;5.0)</td><td char="(" align="char"/><td char="." align="char">278</td><td char="." align="char">14,319</td><td char="(" align="char">19.4 (17.3&#8211;21.8)</td><td char="(" align="char"/></tr><tr><td align="left" colspan="9"><italic>Normal weight</italic></td></tr><tr><td align="left">APOE*2 carriers</td><td char="." align="char">5</td><td char="." align="char">2,370</td><td char="(" align="char">2.1 (0.9&#8211;5.1)</td><td char="(" align="char">0.5 (0.2&#8211;1.2)</td><td char="." align="char">15</td><td char="." align="char">663</td><td char="(" align="char">22.6 (13.6&#8211;37.5)</td><td char="(" align="char">1.6 (0.9&#8211;2.9)</td></tr><tr><td align="left">APOE 3/3</td><td char="." align="char">56</td><td char="." align="char">11,314</td><td char="(" align="char">4.9 (3.8&#8211;6.4)</td><td char="(" align="char"/><td char="." align="char">48</td><td char="." align="char">3,075</td><td char="(" align="char">15.6 (11.8&#8211;20.7)</td><td char="(" align="char"/></tr><tr><td align="left">APOE*4 carriers</td><td char="." align="char">26</td><td char="." align="char">5,080</td><td char="(" align="char">5.1 (3.5&#8211;7.5)</td><td char="(" align="char">1.2 (0.7&#8211;1.9)</td><td char="." align="char">21</td><td char="." align="char">1,286</td><td char="(" align="char">16.3 (10.6&#8211;25.1)</td><td char="(" align="char">1.1 (0.6&#8211;1.8)</td></tr><tr><td align="left">Total</td><td char="." align="char">87</td><td char="." align="char">18,764</td><td char="(" align="char">4.6 (3.8&#8211;5.7)</td><td char="(" align="char"/><td char="." align="char">84</td><td char="." align="char">5,024</td><td char="(" align="char">16.7 (13.5&#8211;20.7)</td><td char="(" align="char"/></tr><tr><td align="left" colspan="9"><italic>Overweight</italic></td></tr><tr><td align="left">APOE*2 carriers</td><td char="." align="char">16</td><td char="." align="char">3,305</td><td char="(" align="char">4.8 (3.0&#8211;7.9)</td><td char="(" align="char">1.4 (0.8&#8211;2.4)</td><td char="." align="char">15</td><td char="." align="char">989</td><td char="(" align="char">15.2 (9.1&#8211;25.2)</td><td char="(" align="char">0.7 (0.4&#8211;1.3)</td></tr><tr><td align="left">APOE 3/3</td><td char="." align="char">51</td><td char="." align="char">13,573</td><td char="(" align="char">3.8 (2.9&#8211;4.9)</td><td char="(" align="char"/><td char="." align="char">92</td><td char="." align="char">4,035</td><td char="(" align="char">22.8 (18.6&#8211;28.0)</td><td char="(" align="char"/></tr><tr><td align="left">APOE*4 carriers</td><td char="." align="char">21</td><td char="." align="char">6,047</td><td char="(" align="char">3.5 (2.3&#8211;5.3)</td><td char="(" align="char">0.8 (0.5&#8211;1.4)</td><td char="." align="char">35</td><td char="." align="char">1,619</td><td char="(" align="char">21.6 (15.5&#8211;30.1)</td><td char="(" align="char">1.0 (0.7&#8211;1.5)</td></tr><tr><td align="left">Total</td><td char="." align="char">88</td><td char="." align="char">22,924</td><td char="(" align="char">3.8 (3.1&#8211;4.7)</td><td char="(" align="char"/><td char="." align="char">142</td><td char="." align="char">6,643</td><td char="(" align="char">21.4 (18.1&#8211;25.2)</td><td char="(" align="char"/></tr><tr><td align="left" colspan="9"><italic>Obese</italic></td></tr><tr><td align="left">APOE*2 carriers</td><td char="." align="char">5</td><td char="." align="char">1,107</td><td char="(" align="char">4.5 (1.9&#8211;10.8)</td><td char="(" align="char">1.1 (0.4&#8211;3.4)</td><td char="." align="char">11</td><td char="." align="char">450</td><td char="(" align="char">24.4 (13.5&#8211;44.1)</td><td char="(" align="char">1.4 (0.7&#8211;3.1)</td></tr><tr><td align="left">APOE 3/3</td><td char="." align="char">19</td><td char="." align="char">3,816</td><td char="(" align="char">5.0 (3.2&#8211;7.8)</td><td char="(" align="char"/><td char="." align="char">31</td><td char="." align="char">1,634</td><td char="(" align="char">19.0 (13.3&#8211;27.0)</td><td char="(" align="char"/></tr><tr><td align="left">APOE*4 carriers</td><td char="." align="char">12</td><td char="." align="char">1,566</td><td char="(" align="char">7.7 (4.4&#8211;13.5)</td><td char="(" align="char">1.6 (0.8&#8211;3.5)</td><td char="." align="char">10</td><td char="." align="char">568</td><td char="(" align="char">17.6 (9.5&#8211;32.7)</td><td char="(" align="char">1.1 (0.5&#8211;2.2)</td></tr><tr><td align="left">Total</td><td char="." align="char">36</td><td char="." align="char">6,489</td><td char="(" align="char">5.5 (4.0&#8211;7.7)</td><td char="(" align="char"/><td char="." align="char">52</td><td char="." align="char">2,651</td><td char="(" align="char">19.6 (14.9&#8211;25.7)</td><td char="(" align="char"/></tr></tbody>
###xml 636 1935 636 1935 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="3"/><th align="left" colspan="2">Follow-up</th><th align="left">Incidence rate</th><th align="left">Hazard ratio</th><th align="left" colspan="2">Follow-up</th><th align="left">Incidence rate</th><th align="left">Hazard ratio</th></tr><tr><th align="left">Deaths</th><th align="left">(py)</th><th align="left">Deaths/1,000 py (95% CI)</th><th align="left">(95% CI)</th><th align="left">Deaths</th><th align="left">(py)</th><th align="left">Deaths/1,000 py (95% CI)</th><th align="left">(95% CI)</th></tr><tr><th align="left" colspan="4">Before 80&#160;years of age</th><th align="left" colspan="4">After 80&#160;years of age</th></tr></thead><tbody><tr><td align="left" colspan="9"><italic>All</italic></td></tr><tr><td align="left">APOE*2 carriers</td><td char="." align="char">26</td><td char="." align="char">6,782</td><td char="(" align="char">3.8 (2.6&#8211;5.6)</td><td char="(" align="char">1.0 (0.6&#8211;1.5)</td><td char="." align="char">41</td><td char="." align="char">2,103</td><td char="(" align="char">19.5 (14.4&#8211;26.5)</td><td char="(" align="char">1.1 (0.8&#8211;1.5)</td></tr><tr><td align="left">APOE 3/3</td><td char="." align="char">126</td><td char="." align="char">28,703</td><td char="(" align="char">4.4 (3.7&#8211;5.2)</td><td char="(" align="char"/><td char="." align="char">171</td><td char="." align="char">8,744</td><td char="(" align="char">19.6 (16.8&#8211;22.7)</td><td char="(" align="char"/></tr><tr><td align="left">APOE*4 carriers</td><td char="." align="char">59</td><td char="." align="char">12,693</td><td char="(" align="char">4.6 (3.6&#8211;6.0)</td><td char="(" align="char">1.1 (0.8&#8211;1.4)</td><td char="." align="char">66</td><td char="." align="char">3,472</td><td char="(" align="char">19.0 (14.9&#8211;24.2)</td><td char="(" align="char">1.1 (0.8&#8211;1.4)</td></tr><tr><td align="left">Total</td><td char="." align="char">211</td><td char="." align="char">48,178</td><td char="(" align="char">4.4 (3.8&#8211;5.0)</td><td char="(" align="char"/><td char="." align="char">278</td><td char="." align="char">14,319</td><td char="(" align="char">19.4 (17.3&#8211;21.8)</td><td char="(" align="char"/></tr><tr><td align="left" colspan="9"><italic>Normal weight</italic></td></tr><tr><td align="left">APOE*2 carriers</td><td char="." align="char">5</td><td char="." align="char">2,370</td><td char="(" align="char">2.1 (0.9&#8211;5.1)</td><td char="(" align="char">0.5 (0.2&#8211;1.2)</td><td char="." align="char">15</td><td char="." align="char">663</td><td char="(" align="char">22.6 (13.6&#8211;37.5)</td><td char="(" align="char">1.6 (0.9&#8211;2.9)</td></tr><tr><td align="left">APOE 3/3</td><td char="." align="char">56</td><td char="." align="char">11,314</td><td char="(" align="char">4.9 (3.8&#8211;6.4)</td><td char="(" align="char"/><td char="." align="char">48</td><td char="." align="char">3,075</td><td char="(" align="char">15.6 (11.8&#8211;20.7)</td><td char="(" align="char"/></tr><tr><td align="left">APOE*4 carriers</td><td char="." align="char">26</td><td char="." align="char">5,080</td><td char="(" align="char">5.1 (3.5&#8211;7.5)</td><td char="(" align="char">1.2 (0.7&#8211;1.9)</td><td char="." align="char">21</td><td char="." align="char">1,286</td><td char="(" align="char">16.3 (10.6&#8211;25.1)</td><td char="(" align="char">1.1 (0.6&#8211;1.8)</td></tr><tr><td align="left">Total</td><td char="." align="char">87</td><td char="." align="char">18,764</td><td char="(" align="char">4.6 (3.8&#8211;5.7)</td><td char="(" align="char"/><td char="." align="char">84</td><td char="." align="char">5,024</td><td char="(" align="char">16.7 (13.5&#8211;20.7)</td><td char="(" align="char"/></tr><tr><td align="left" colspan="9"><italic>Overweight</italic></td></tr><tr><td align="left">APOE*2 carriers</td><td char="." align="char">16</td><td char="." align="char">3,305</td><td char="(" align="char">4.8 (3.0&#8211;7.9)</td><td char="(" align="char">1.4 (0.8&#8211;2.4)</td><td char="." align="char">15</td><td char="." align="char">989</td><td char="(" align="char">15.2 (9.1&#8211;25.2)</td><td char="(" align="char">0.7 (0.4&#8211;1.3)</td></tr><tr><td align="left">APOE 3/3</td><td char="." align="char">51</td><td char="." align="char">13,573</td><td char="(" align="char">3.8 (2.9&#8211;4.9)</td><td char="(" align="char"/><td char="." align="char">92</td><td char="." align="char">4,035</td><td char="(" align="char">22.8 (18.6&#8211;28.0)</td><td char="(" align="char"/></tr><tr><td align="left">APOE*4 carriers</td><td char="." align="char">21</td><td char="." align="char">6,047</td><td char="(" align="char">3.5 (2.3&#8211;5.3)</td><td char="(" align="char">0.8 (0.5&#8211;1.4)</td><td char="." align="char">35</td><td char="." align="char">1,619</td><td char="(" align="char">21.6 (15.5&#8211;30.1)</td><td char="(" align="char">1.0 (0.7&#8211;1.5)</td></tr><tr><td align="left">Total</td><td char="." align="char">88</td><td char="." align="char">22,924</td><td char="(" align="char">3.8 (3.1&#8211;4.7)</td><td char="(" align="char"/><td char="." align="char">142</td><td char="." align="char">6,643</td><td char="(" align="char">21.4 (18.1&#8211;25.2)</td><td char="(" align="char"/></tr><tr><td align="left" colspan="9"><italic>Obese</italic></td></tr><tr><td align="left">APOE*2 carriers</td><td char="." align="char">5</td><td char="." align="char">1,107</td><td char="(" align="char">4.5 (1.9&#8211;10.8)</td><td char="(" align="char">1.1 (0.4&#8211;3.4)</td><td char="." align="char">11</td><td char="." align="char">450</td><td char="(" align="char">24.4 (13.5&#8211;44.1)</td><td char="(" align="char">1.4 (0.7&#8211;3.1)</td></tr><tr><td align="left">APOE 3/3</td><td char="." align="char">19</td><td char="." align="char">3,816</td><td char="(" align="char">5.0 (3.2&#8211;7.8)</td><td char="(" align="char"/><td char="." align="char">31</td><td char="." align="char">1,634</td><td char="(" align="char">19.0 (13.3&#8211;27.0)</td><td char="(" align="char"/></tr><tr><td align="left">APOE*4 carriers</td><td char="." align="char">12</td><td char="." align="char">1,566</td><td char="(" align="char">7.7 (4.4&#8211;13.5)</td><td char="(" align="char">1.6 (0.8&#8211;3.5)</td><td char="." align="char">10</td><td char="." align="char">568</td><td char="(" align="char">17.6 (9.5&#8211;32.7)</td><td char="(" align="char">1.1 (0.5&#8211;2.2)</td></tr><tr><td align="left">Total</td><td char="." align="char">36</td><td char="." align="char">6,489</td><td char="(" align="char">5.5 (4.0&#8211;7.7)</td><td char="(" align="char"/><td char="." align="char">52</td><td char="." align="char">2,651</td><td char="(" align="char">19.6 (14.9&#8211;25.7)</td><td char="(" align="char"/></tr></tbody></table>
###xml 1935 2119 1935 2119 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="31">Hazard ratios adjusted for sex, waist-hip-ratio, smoking, education level, total serum cholesterol, HDL cholesterol hypertension and diabetes; py: person-years; CI: Confidence interval</p>
###xml 1935 2119 1935 2119 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="31">Hazard ratios adjusted for sex, waist-hip-ratio, smoking, education level, total serum cholesterol, HDL cholesterol hypertension and diabetes; py: person-years; CI: Confidence interval</p></table-wrap-foot>
###xml 541 2119 541 2119 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab3"><label>Table&#160;3</label><caption><p textid="30">Incidence rates and hazard ratios for CHD mortality by <italic>APOE</italic> genotypes and BMI categories</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="3"/><th align="left" colspan="2">Follow-up</th><th align="left">Incidence rate</th><th align="left">Hazard ratio</th><th align="left" colspan="2">Follow-up</th><th align="left">Incidence rate</th><th align="left">Hazard ratio</th></tr><tr><th align="left">Deaths</th><th align="left">(py)</th><th align="left">Deaths/1,000 py (95% CI)</th><th align="left">(95% CI)</th><th align="left">Deaths</th><th align="left">(py)</th><th align="left">Deaths/1,000 py (95% CI)</th><th align="left">(95% CI)</th></tr><tr><th align="left" colspan="4">Before 80&#160;years of age</th><th align="left" colspan="4">After 80&#160;years of age</th></tr></thead><tbody><tr><td align="left" colspan="9"><italic>All</italic></td></tr><tr><td align="left">APOE*2 carriers</td><td char="." align="char">26</td><td char="." align="char">6,782</td><td char="(" align="char">3.8 (2.6&#8211;5.6)</td><td char="(" align="char">1.0 (0.6&#8211;1.5)</td><td char="." align="char">41</td><td char="." align="char">2,103</td><td char="(" align="char">19.5 (14.4&#8211;26.5)</td><td char="(" align="char">1.1 (0.8&#8211;1.5)</td></tr><tr><td align="left">APOE 3/3</td><td char="." align="char">126</td><td char="." align="char">28,703</td><td char="(" align="char">4.4 (3.7&#8211;5.2)</td><td char="(" align="char"/><td char="." align="char">171</td><td char="." align="char">8,744</td><td char="(" align="char">19.6 (16.8&#8211;22.7)</td><td char="(" align="char"/></tr><tr><td align="left">APOE*4 carriers</td><td char="." align="char">59</td><td char="." align="char">12,693</td><td char="(" align="char">4.6 (3.6&#8211;6.0)</td><td char="(" align="char">1.1 (0.8&#8211;1.4)</td><td char="." align="char">66</td><td char="." align="char">3,472</td><td char="(" align="char">19.0 (14.9&#8211;24.2)</td><td char="(" align="char">1.1 (0.8&#8211;1.4)</td></tr><tr><td align="left">Total</td><td char="." align="char">211</td><td char="." align="char">48,178</td><td char="(" align="char">4.4 (3.8&#8211;5.0)</td><td char="(" align="char"/><td char="." align="char">278</td><td char="." align="char">14,319</td><td char="(" align="char">19.4 (17.3&#8211;21.8)</td><td char="(" align="char"/></tr><tr><td align="left" colspan="9"><italic>Normal weight</italic></td></tr><tr><td align="left">APOE*2 carriers</td><td char="." align="char">5</td><td char="." align="char">2,370</td><td char="(" align="char">2.1 (0.9&#8211;5.1)</td><td char="(" align="char">0.5 (0.2&#8211;1.2)</td><td char="." align="char">15</td><td char="." align="char">663</td><td char="(" align="char">22.6 (13.6&#8211;37.5)</td><td char="(" align="char">1.6 (0.9&#8211;2.9)</td></tr><tr><td align="left">APOE 3/3</td><td char="." align="char">56</td><td char="." align="char">11,314</td><td char="(" align="char">4.9 (3.8&#8211;6.4)</td><td char="(" align="char"/><td char="." align="char">48</td><td char="." align="char">3,075</td><td char="(" align="char">15.6 (11.8&#8211;20.7)</td><td char="(" align="char"/></tr><tr><td align="left">APOE*4 carriers</td><td char="." align="char">26</td><td char="." align="char">5,080</td><td char="(" align="char">5.1 (3.5&#8211;7.5)</td><td char="(" align="char">1.2 (0.7&#8211;1.9)</td><td char="." align="char">21</td><td char="." align="char">1,286</td><td char="(" align="char">16.3 (10.6&#8211;25.1)</td><td char="(" align="char">1.1 (0.6&#8211;1.8)</td></tr><tr><td align="left">Total</td><td char="." align="char">87</td><td char="." align="char">18,764</td><td char="(" align="char">4.6 (3.8&#8211;5.7)</td><td char="(" align="char"/><td char="." align="char">84</td><td char="." align="char">5,024</td><td char="(" align="char">16.7 (13.5&#8211;20.7)</td><td char="(" align="char"/></tr><tr><td align="left" colspan="9"><italic>Overweight</italic></td></tr><tr><td align="left">APOE*2 carriers</td><td char="." align="char">16</td><td char="." align="char">3,305</td><td char="(" align="char">4.8 (3.0&#8211;7.9)</td><td char="(" align="char">1.4 (0.8&#8211;2.4)</td><td char="." align="char">15</td><td char="." align="char">989</td><td char="(" align="char">15.2 (9.1&#8211;25.2)</td><td char="(" align="char">0.7 (0.4&#8211;1.3)</td></tr><tr><td align="left">APOE 3/3</td><td char="." align="char">51</td><td char="." align="char">13,573</td><td char="(" align="char">3.8 (2.9&#8211;4.9)</td><td char="(" align="char"/><td char="." align="char">92</td><td char="." align="char">4,035</td><td char="(" align="char">22.8 (18.6&#8211;28.0)</td><td char="(" align="char"/></tr><tr><td align="left">APOE*4 carriers</td><td char="." align="char">21</td><td char="." align="char">6,047</td><td char="(" align="char">3.5 (2.3&#8211;5.3)</td><td char="(" align="char">0.8 (0.5&#8211;1.4)</td><td char="." align="char">35</td><td char="." align="char">1,619</td><td char="(" align="char">21.6 (15.5&#8211;30.1)</td><td char="(" align="char">1.0 (0.7&#8211;1.5)</td></tr><tr><td align="left">Total</td><td char="." align="char">88</td><td char="." align="char">22,924</td><td char="(" align="char">3.8 (3.1&#8211;4.7)</td><td char="(" align="char"/><td char="." align="char">142</td><td char="." align="char">6,643</td><td char="(" align="char">21.4 (18.1&#8211;25.2)</td><td char="(" align="char"/></tr><tr><td align="left" colspan="9"><italic>Obese</italic></td></tr><tr><td align="left">APOE*2 carriers</td><td char="." align="char">5</td><td char="." align="char">1,107</td><td char="(" align="char">4.5 (1.9&#8211;10.8)</td><td char="(" align="char">1.1 (0.4&#8211;3.4)</td><td char="." align="char">11</td><td char="." align="char">450</td><td char="(" align="char">24.4 (13.5&#8211;44.1)</td><td char="(" align="char">1.4 (0.7&#8211;3.1)</td></tr><tr><td align="left">APOE 3/3</td><td char="." align="char">19</td><td char="." align="char">3,816</td><td char="(" align="char">5.0 (3.2&#8211;7.8)</td><td char="(" align="char"/><td char="." align="char">31</td><td char="." align="char">1,634</td><td char="(" align="char">19.0 (13.3&#8211;27.0)</td><td char="(" align="char"/></tr><tr><td align="left">APOE*4 carriers</td><td char="." align="char">12</td><td char="." align="char">1,566</td><td char="(" align="char">7.7 (4.4&#8211;13.5)</td><td char="(" align="char">1.6 (0.8&#8211;3.5)</td><td char="." align="char">10</td><td char="." align="char">568</td><td char="(" align="char">17.6 (9.5&#8211;32.7)</td><td char="(" align="char">1.1 (0.5&#8211;2.2)</td></tr><tr><td align="left">Total</td><td char="." align="char">36</td><td char="." align="char">6,489</td><td char="(" align="char">5.5 (4.0&#8211;7.7)</td><td char="(" align="char"/><td char="." align="char">52</td><td char="." align="char">2,651</td><td char="(" align="char">19.6 (14.9&#8211;25.7)</td><td char="(" align="char"/></tr></tbody></table><table-wrap-foot><p textid="31">Hazard ratios adjusted for sex, waist-hip-ratio, smoking, education level, total serum cholesterol, HDL cholesterol hypertension and diabetes; py: person-years; CI: Confidence interval</p></table-wrap-foot></table-wrap>
###xml 517 529 <span type="species:ncbi:9606">participants</span>
###xml 2082 2088 <span type="species:ncbi:9606">person</span>
To investigate whether the lower risk of mortality observed among normal weight APOE*2 carriers was due to a lower risk of mortality from CHD, we calculated the HRs separately for CHD mortality. APOE genotype was not significantly associated with CHD mortality. Analysis within BMI strata showed that normal weight APOE*2 carriers tended to have lower risks of CHD mortality (adjusted HR [95% CI] = 0.5 [0.2-1.2]). No differences in the risk of CHD mortality between genotype groups were found in overweight or obese participants (Table 3). Table 3Incidence rates and hazard ratios for CHD mortality by APOE genotypes and BMI categoriesFollow-upIncidence rateHazard ratioFollow-upIncidence rateHazard ratioDeaths(py)Deaths/1,000 py (95% CI)(95% CI)Deaths(py)Deaths/1,000 py (95% CI)(95% CI)Before 80 years of ageAfter 80 years of ageAllAPOE*2 carriers266,7823.8 (2.6-5.6)1.0 (0.6-1.5)412,10319.5 (14.4-26.5)1.1 (0.8-1.5)APOE 3/312628,7034.4 (3.7-5.2)1718,74419.6 (16.8-22.7)APOE*4 carriers5912,6934.6 (3.6-6.0)1.1 (0.8-1.4)663,47219.0 (14.9-24.2)1.1 (0.8-1.4)Total21148,1784.4 (3.8-5.0)27814,31919.4 (17.3-21.8)Normal weightAPOE*2 carriers52,3702.1 (0.9-5.1)0.5 (0.2-1.2)1566322.6 (13.6-37.5)1.6 (0.9-2.9)APOE 3/35611,3144.9 (3.8-6.4)483,07515.6 (11.8-20.7)APOE*4 carriers265,0805.1 (3.5-7.5)1.2 (0.7-1.9)211,28616.3 (10.6-25.1)1.1 (0.6-1.8)Total8718,7644.6 (3.8-5.7)845,02416.7 (13.5-20.7)OverweightAPOE*2 carriers163,3054.8 (3.0-7.9)1.4 (0.8-2.4)1598915.2 (9.1-25.2)0.7 (0.4-1.3)APOE 3/35113,5733.8 (2.9-4.9)924,03522.8 (18.6-28.0)APOE*4 carriers216,0473.5 (2.3-5.3)0.8 (0.5-1.4)351,61921.6 (15.5-30.1)1.0 (0.7-1.5)Total8822,9243.8 (3.1-4.7)1426,64321.4 (18.1-25.2)ObeseAPOE*2 carriers51,1074.5 (1.9-10.8)1.1 (0.4-3.4)1145024.4 (13.5-44.1)1.4 (0.7-3.1)APOE 3/3193,8165.0 (3.2-7.8)311,63419.0 (13.3-27.0)APOE*4 carriers121,5667.7 (4.4-13.5)1.6 (0.8-3.5)1056817.6 (9.5-32.7)1.1 (0.5-2.2)Total366,4895.5 (4.0-7.7)522,65119.6 (14.9-25.7)Hazard ratios adjusted for sex, waist-hip-ratio, smoking, education level, total serum cholesterol, HDL cholesterol hypertension and diabetes; py: person-years; CI: Confidence interval
###end p 29
###begin p 30
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
Incidence rates and hazard ratios for CHD mortality by APOE genotypes and BMI categories
###end p 30
###begin p 31
###xml 147 153 <span type="species:ncbi:9606">person</span>
Hazard ratios adjusted for sex, waist-hip-ratio, smoking, education level, total serum cholesterol, HDL cholesterol hypertension and diabetes; py: person-years; CI: Confidence interval
###end p 31
###begin title 32
Discussion
###end title 32
###begin p 33
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 222 227 222 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 309 314 309 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
Our study shows that the APOE*2 allele has a protective effect on overall mortality. This protective effect seems to be limited to mortality from CHD. Analyses within BMI strata demonstrated that this genetic advantage of APOE*2 was observed only in normal weight individuals, but not in overweight and obese APOE*2 carriers.
###end p 33
###begin p 34
###xml 128 132 128 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 482 486 482 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 555 559 555 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 615 616 615 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
###xml 621 623 621 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR34">34</xref>
###xml 684 688 684 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 692 693 692 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 695 697 695 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 699 701 699 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 738 742 738 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 746 747 746 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 748 750 748 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 854 858 854 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 876 878 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 880 882 880 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 268 280 <span type="species:ncbi:9606">participants</span>
The results of the present analyses may seem to contradict our earlier work in this population. We previously reported that the APOE gene was not significantly related to mortality [12]. While our findings come from the same population, the mean follow-up time of the participants has increased from 5.4 years to 11.1 years and the number of deaths increased by 53% from 18% to 34%. This extended follow-up has improved the statistical power of our study to show a modest effect of APOE genotype on overall mortality. Research on the relationship between APOE and mortality has merely provided conflicting results [6-19, 34]. Three out of eleven studies showed a protective effect of APOE*2 [6, 14, 18]. and three a deleterious effect of APOE*4 [8-10]. The latter effect may partly mediated by the increased risk of Alzheimer disease in association with APOE*4 and mortality [10, 11].
###end p 34
###begin p 35
###xml 133 137 133 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 423 425 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR35">35</xref>
###xml 576 580 576 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 680 684 680 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 762 764 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR36">36</xref>
###xml 385 390 <span type="species:ncbi:9606">human</span>
Note that our analysis showed small significant difference in the Kaplan-Meier survival curves, demonstrating a protective effect of APOE*2 before age 80. This may be due to the effect of age that becomes apparent when performing survival analysis with age as time scale, as we did in the present paper. Such finding is compatible with previous reports suggesting that genes affecting human lifespan might be age-specific [35]. Genetic and environmental interactions at older ages vary from those at early ages and therefore explain the differences in the association between APOE and mortality before and after 80 years of age. A previous report showed that among nonagenarians, APOE genotype has no effect on cognitive function, cognitive decline or survival [36].
###end p 35
###begin p 36
###xml 31 33 31 33 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 34 36 34 36 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 104 108 104 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 259 264 259 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 338 342 338 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 430 434 430 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 526 530 526 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 593 595 593 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 597 599 597 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">37</xref>
###xml 706 710 706 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 797 801 797 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 876 878 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 1138 1142 1138 1142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 1155 1157 1155 1157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 1158 1160 1158 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 1162 1164 1162 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">37</xref>
###xml 1293 1297 1293 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 1408 1412 1408 1412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 1585 1587 1585 1587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR38">38</xref>
###xml 1664 1666 1664 1666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR39">39</xref>
In line with previous studies [20-22], we found that the total serum cholesterol levels associated with APOE genotype differed between normal weight, overweight and obese individuals. As expected, mean levels of total serum cholesterol increased with BMI and APOE*2 carriers had the lowest mean total serum cholesterol in each BMI group. APOE*4 carriers had higher cholesterol levels and lower HDL-cholesterol concentrations than APOE*2 carriers despite the presence of a lower BMI and equal WHR. Previous reports showed that APOE genotype, BMI and WHR determine together the lipid levels [20-22, 37]. However, in our study abdominal fat, as measured by WHR, did not have any effect on the lipid levels by APOE genotype, while BMI was an important determinant. The significant interaction between APOE genotype and BMI in relation to total serum cholesterol found previously [20], was also supported by this study. Although the mechanism of such interaction has not been yet elucidated, evidence suggests that obesity and abdominal fat increase low density lipoprotein cholesterol and therefore total cholesterol at a higher degree among APOE*4 carriers [20-22, 37]. This is in line with our observation that the deleterious effect of increased BMI prevails over the beneficial effects of the APOE*2 allele. Furthermore, previous research in the Rotterdam Study and the Dutch population indicated that among APOE*2 homozygous carriers, the expression of Hyperlipoproteinemia type III is determined to a great extent by hyperinsulinemia and the presence of insulin resistance syndrome [38], conferring and increased risk of CHD through accelerated atherosclerosis [39].
###end p 36
###begin p 37
###xml 92 96 92 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 217 221 217 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 289 294 289 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 567 571 567 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
###xml 626 631 626 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 933 938 933 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE*</italic>
###xml 989 993 989 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE</italic>
Although the association between high BMI and high cholesterol levels is well known and the APOE gene is associated with cholesterol levels as previously described, this is the first study that examined the effect of APOE genotype on mortality in BMI strata. We found that presence of the APOE*2 allele was associated with a decreased risk of mortality only in normal weight individuals and that this lower risk was partly explained by lower risk of CHD mortality. These results were in line with the lower total cholesterol and higher HDL levels among normal weight APOE*2 carriers. Our finding that the protective effect of APOE*2 was only found in normal weight individuals suggests that the negative influences of increasing BMI outweigh the positive effects of genetic predisposition. When these results are confirmed by other population-based studies, a challenging question remains whether weight loss in overweight and obese APOE*2 carriers restores the genetic advantage of their APOE status.
###end p 37
###begin title 38
Acknowledgements
###end title 38
###begin p 39
The Rotterdam Study is supported by the Erasmus Medical Center and Erasmus University Rotterdam, the Netherlands Organization for Scientific Research (NWO), the Netherlands Organization for Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry of Health, Welfare and Sports, the European Commission (DGXII), the Municipality of Rotterdam, and the Centre for Medical Systems Biology (CMSB). The contributions of the general practitioners and pharmacists of the Ommoord district to the Rotterdam Study are greatly acknowledged.
###end p 39
###begin p 40
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Open Access</bold>
Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
###end p 40
###begin title 41
References
###end title 41
###begin article-title 42
Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review
###end article-title 42
###begin article-title 43
Apolipoproteins and atherosclerosis. Apolipoprotein E and apolipoprotein(a) as candidate genes of premature development of atherosclerosis
###end article-title 43
###begin article-title 44
###xml 106 109 <span type="species:ncbi:9606">men</span>
Apolipoprotein E polymorphism and carotid artery intima-media thickness in a random sample of middle-aged men
###end article-title 44
###begin article-title 45
Apolipoprotein E and atherosclerosis: beyond lipid effect
###end article-title 45
###begin article-title 46
Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease
###end article-title 46
###begin article-title 47
Mortality and apolipoprotein E in Hispanic, African-American, and Caucasian elders
###end article-title 47
###begin article-title 48
Effect of serum lipids, lipoproteins, and apolipoproteins on vascular and nonvascular mortality in the elderly
###end article-title 48
###begin article-title 49
###xml 72 77 <span type="species:ncbi:9606">women</span>
Apolipoprotein E phenotype, arterial disease, and mortality among older women: the study of osteoporotic fractures
###end article-title 49
###begin article-title 50
###xml 116 119 <span type="species:ncbi:9606">men</span>
Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men
###end article-title 50
###begin article-title 51
###xml 54 60 <span type="species:ncbi:9606">people</span>
Predictors of cognitive decline and mortality of aged people over a 10-year period
###end article-title 51
###begin article-title 52
Apolipoprotein E genotype and mortality: findings from the Cache County Study
###end article-title 52
###begin article-title 53
Apolipoprotein E and longevity: the Rotterdam Study
###end article-title 53
###begin article-title 54
Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects
###end article-title 54
###begin article-title 55
Apolipoprotein E phenotype alone does not influence survival in Alzheimer's disease: a population-based longitudinal study
###end article-title 55
###begin article-title 56
Association of APOE epsilon2/epsilon3/epsilon4 and promoter gene variants with dementia but not cardiovascular mortality in old age
###end article-title 56
###begin article-title 57
APOE epsilon4 does not predict mortality, cognitive decline, or dementia in the oldest old
###end article-title 57
###begin article-title 58
A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality
###end article-title 58
###begin article-title 59
Mortality, apolipoprotein E in African-American, and White elders: an attempted replication
###end article-title 59
###begin article-title 60
Relationship between plasma lipids and all-cause mortality in nondemented elderly
###end article-title 60
###begin article-title 61
Obesity and alcohol modulate the effect of apolipoprotein E polymorphism on lipids and insulin
###end article-title 61
###begin article-title 62
Apolipoprotein E polymorphism modulates the association between obesity and dyslipidemias during young adulthood: the Bogalusa Heart Study
###end article-title 62
###begin article-title 63
Interactions between lifestyle-related factors and the ApoE polymorphism on plasma lipids and apolipoproteins. The EARS Study. European Atherosclerosis Research Study
###end article-title 63
###begin article-title 64
Determinants of disease and disability in the elderly: the Rotterdam Elderly Study
###end article-title 64
###begin article-title 65
Cholesterol determinations. A comparative study of methods with special reference to enzymatic procedures
###end article-title 65
###begin article-title 66
Apolipoprotein E genotype and progression of Alzheimer's disease: the Rotterdam Study
###end article-title 66
###begin article-title 67
Age at diagnosis and the choice of survival analysis methods in cancer epidemiology
###end article-title 67
###begin article-title 68
Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale
###end article-title 68
###begin article-title 69
Partial residuals for the proportional hazards regression model
###end article-title 69
###begin article-title 70
###xml 26 31 <span type="species:ncbi:9606">human</span>
Genetic associations with human longevity at the APOE and ACE loci
###end article-title 70
###begin article-title 71
###xml 38 43 <span type="species:ncbi:9606">human</span>
The quest for genetic determinants of human longevity: challenges and insights
###end article-title 71
###begin article-title 72
Apolipoprotein E genotypes: relationship to cognitive functioning, cognitive decline, and survival in nonagenarians
###end article-title 72
###begin article-title 73
###xml 101 106 <span type="species:ncbi:9606">women</span>
Apolipoprotein E polymorphism alters the association between body fatness and plasma lipoproteins in women
###end article-title 73
###begin article-title 74
Expression of type III hyperlipoproteinemia in apolipoprotein E2 (Arg158 --> Cys) homozygotes is associated with hyperinsulinemia
###end article-title 74
###begin article-title 75
Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes
###end article-title 75

